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ABSTRACT
This study was carried out in order to investigate the human genetic 
effects of exposure to benzene in 66 male workers of a refinery  
population and the results compared with 33 control workers in the same 
re finery, not known to have had exposure to benzene. Questionnaires 
were used to determine various life style factors such as smoking, 
drinking and exposure to ionising radiation as examples of known 
confounding variables. In  addition, experiments were designed to 
investigate the mechanism of benzene carcinogenicity using cell 
transformation techniques, together with a molecular dosimetry approach 
in an attempt to identify and quantify any interaction with benzene 
metabolites and DNA.
The results from the human studies showed no difference between the 
groups when effects such as mitogen-induced blastogenesis, 
proliferative rate index, sister chromatid exchange and urine  
mutagenicity were measured. There was a suggestion of a decrease in  
mitogenic response with age in both exposed and control individuals in  
the mitogen induced blastogenesis experiments, which was consistent 
with other studies. Although no difference in the number of revertant 
colonies in strain TA 98 and 100 was demonstrated between the high 
and low urinary phenol groups there was a correlation between the 
number of revertants and the ages of the individuals as a whole. One 
statistical test used in the examination of the chromosome aberration  
data suggested a statistically significant increase in aberrations in the 
exposed group to the control groups, and this increase could be the 
result of benzene exposure.
-  i -
Cell transformation studies using C3H10T£ cell lines did not indicate
that benzene had any in itiating carcinogenic properties in v itro  using
the two stage model of carcinogenesis. Furthermore, molecular
14dosimetry studies using C -  labelled benzene in vivo demonstrated 
only a very weak interation between benzene metabolites and rat liver 
DNA.
All the methods used in this study generated negative data except for 
that to detect chromosome damage. This method showed a slight 
increase in damage in exposed workers by comparison with the controls 
suggesting that benzene may be a weak clastogen at low doses.
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CHAPTER 1
INTRODUCTION
HISTORICAL PERSPECTIVE
Structure and Discovery of Benzene
The b irth  of organic chemistry coincided with the close of the Industrial 
Revolution, when the manufacture of coal gas on an industrial basis in  
1812 laid the foundations of the coal-tar chemical industry. In  1825 
Michael Faraday discovered benzene in the distillate obtained by  
pyrolysis of whale oil produced by the Portable Gas Company. 
However, it  was August Wilhelm Von Hofmann (1818-92), a German 
chemist, who firs t proved conclusively that coal-tar contained benzene 
and he made the fact public in 1845. Benzene is a volatile, colourless 
and flammable liquid hydrocarbon with a distinct odour, its formula 
being CgHg. The arrangement of six carbon atoms as a closed ring of 
the benzene nucleus was firs t proposed as one of three structures in  
1866 and confirmed in 1869 by Kekule. English chemists follow
Hoffmann’s nomenclature and use the term benzene, although benzol has 
been favoured in Germany and benzole in France.
Benzene is handled in industry in two distinctly different ways. In  
the f irs t , i t  is produced in large quantities in closed mechanical 
systems, and the industries involved include the distillation of coal and 
coal-tar. It  is also used in the blending of motor fuels, and as a 
chemical raw material in the synthesis of styrene, phenol, cyclohexane, 
aniline and other products used in the production of drugs, dyes and 
insecticides. In  the second, it  was historically used as a solvent or 
diluent, and the industries involved have included the rubber industry , 
artificial leather manufacture, photogravure colour prin ting and the 
manufacturing of paints and varnishes, to name but a few.
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Although benzene has now been replaced as a solvent and diluent in  
many of these industries, it  was formerly produced in large quantities 
from the light oil derived by high temperature pyrolysis of coal for 
domestic town gas but now from the low temperature coking process 
used in the steel industry. An important source today is in the 
refining of crude oil. Although the amount of benzene in crude oil is 
small, when the benzene concentration in a petroleum fraction is 
increased by a catalytic and thermal reaction, recovery becomes a viable 
proposition. The benzene is selectively extracted from the appropriate 
fraction by partitioning into an immisible solvent such as sulpholane. 
The benzene thereafter is distilled from this solvent/benzene mixture. 
In  the past benzene has been produced from toluene by  
hydro-dealkylation, but owing to the requirement for lower lead levels 
in motor gasolines, the need for toluene in gasoline has increased. 
Motor gasoline contains between 1-15% benzene and the amount varies 
depending on the origin of the crude oil and the particular refin ing  
process employed.
Of all the hydrocarbons, benzene is outstanding because of its serious 
toxic effects on the bone marrow. The response of dogs and guinea 
pigs exposed to crude and commercial benzoles (fractions of coal-tar 
containing toluene, xylene and traces of phenol and carbon disulphide) 
is characteristic of benzene poisoning, and the toxicological effect is 
due prim arily to the benzene content of the solvent used and not the 
the impurities. (Schrenk et al 1940).
2
Acute Benzene Poisoning
Except for a few cases of accidental or suicidal ingestion, poisoning in  
industry is due to the inhalation of the vapour of benzene. Acute 
poisoning may occur by inhalation from cleaning vats, painting tanks or 
the breakage of distillation apparatus. The symptoms are excitement, 
incoherent speech, flushing, headache, vertigo, nausea, parathesiae in 
the hands and feet and i f  exposure is continued, narcosis.
Chronic Benzene Poisoning
In  the latter years of the 19th century, the use of benzene as a rubber 
solvent led to small outbreaks of purpura haemorrhagica with a number 
of deaths from aplastic anaemia. The invention of the pneumatic tyre  
in 1888 immediately made the safety bicycle popular. Within nine years 
of the tyre  being manufactured the benzene-rubber cement used to seal 
its edges had caused four fatal cases of benzene poisoning among nine 
women engaged in a tyre  factory in Stockholm. This was announced to 
the world in 1897 by the Swedish toxicologist Santesson before the 
Twelfth International Congress of Medicine in Moscow. Selling (1910) 
reported three similar cases in an American cannery among girls
employed using a solution of rubber in benzene for sealing tins.
Selling was the firs t to point out that the important characteristic of
benzene poisoning was not the purpura haemorrhagica but the
leucopaenia with extreme reduction of the granular leucocytes caused by  
aplasia of the bone marrow.
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I t  is ironic today that this leucotoxic action of benzene prompted its 
adoption in the treatment of 80 cases of leukaemia (Koranyi 1914). 
Perhaps not surprisingly, good results were rare and this drastic 
treatment was quickly discontinued. However, Koranyi established 
another important effect of benzene treatment, namely that repeated 
small doses of 0.25g daily 'excited’ erythropoieses, a phenomenon that 
is referred to later.
The firs t cases of chronic benzene poisoning to be discovered in Great 
Britain were reported by Dr Veitch of Edinburgh to Dr Legge, (la tte rly  
Sir Thomas Legge) of the Factory Department of the Home Office, 
London in January 1918 (Legge 1919). The three men involved had 
been employed in a rubber works spreading balloon fabric, the rubber 
for this being dissolved in benzene. As a result xylene was 
substituted for benzene and medical supervision of workers involved in  
similar processes was instituted. Dr Alice Hamilton (1928) secured the 
same benefit for the workers in the United States after a six year 
campaign, where the problems are on a much larger scale. Toluene 
and rubber latex were thereafter substituted for benzene. Around 1933, 
benzene was introduced instead of turpentine in the photogravure 
printing process when quicker drying of the inks was made necessary 
by the invention of rotary presses which were much faster. In  the 
United States the process was called rotogravure. In  1939, Greenberg 
et al discovered three plants in New York City which employed 350 
males and used 50,000 gallons of benzene per month. Exposures 
ranged from 11 to 1,060 parts per million and occurred as a result of 
the evaporation from troughs on the machines and the common practice
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of using benzene as a hand cleaner! Owing to the high number of 
benzene poisonings, the use of benzene was discontinued.
In  1939 a series of detailed studies appeared describing the 
characteristics of benzene poisoning. (Hunter 1939, E rf and Rhodes 
1939, Mallory et al 1939). Mallory et al (1939) found the picture in 
the bone marrow to vary from severe hypoplasia to the most extreme 
hyperplasia, and they even recorded extramedullary haemopoiesis. 
In terestingly, hyperplasia proved the more common of the two reactions. 
It  was found only in those with prolonged exposure, whereas hypoplasia 
followed either short or long contact.
Benzene and Leukaemia
Although benzene had been known to have toxic effects on the bone 
marrow for over half a century, it  was not until 1928 that the action of 
benzene was shown to be a cause of leukaemia. (Delore and Borgomano 
1928). From this firs t observation, there have been many leukaemias 
in people exposed to benzene that have been the subject of case 
reports. Those that have been reported up to 1977 were reviewed by  
Maltoni (1983) and are shown in Table 1.
From Table 1 it  can be seen that the most frequent form of leukaemia is 
acute myeloid leukaemia. The majority of the leukaemias occurred in 
patients with a history of myelotoxicity. Most of the cases were from 
shoe factories and rotogravure plants in Ita ly , others from France and 
Germany.
5
TABLE 1
CASE REPORTS OF HAEMO-LYMPHO-RETICULAR NEOPLASIAS
("LEUKAEMIAS") OBSERVED IN INDIVIDUALS EXPOSED TO
BENZENE THAT HAVE BEEN REPORTED IN  THE SCIENTIFIC
LITERATURE UNTIL 1977
TYPE OF NEOPLASIA NO.OF CASES NO.OF REPORTS
Acute Myelogenous Leukaemia 58 28
Erythroleukaemia 16 10
Acute Monocytic Leukaemia 3 2
Chronic Myelogenous Leukaemia 27 7
Myelofibrosis /Myeloid Metaplasia 7 5
Thrombocythemia 1 1
Acute Lymphoblastic Leukaemia 8 4
Chronic Lymphoblastic Leukaemia 9 7
Lymphomas 14 7
TOTAL: 143 71
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Epidemiology studies in Japan (Ishimaru et al 1971) and the United 
States (Infante et al 1977) later confirmed an increased risk  of 
leukaemia in those chronically exposed to benzene. These and other 
epidemiology studies are discussed in more detail later. However, in  
general, the leukaemias occurred in subjects who had evidence of 
marrow hypoplasia. In some cases there was a long latent period (up  
to 12 years) between the cessation of exposure and the occurrence of 
the leukaemia. Furthermore, some of the cases with only marrow 
hypoplasia had evidence of atypical marrow cells that were progressing 
towards acute leukaemia (Maltoni 1983).
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EPIDEMIOLOGY
The human epidemiology evidence for an association between benzene 
and leukaemia is substantial. Table 2 summarises the major studies in  
terms of increased leukaemia risk in the populations who were exposed 
to benzene.
Aksoy et al (1980) formalized their clinical experience with leukaemia in  
shoe workers in Istanbul by describing 42 leukaemia cases in 1980, 
updating previous studies in 1972 and 1976. These cases had been 
identified between 1967 and 1975. In  26% of the cases, the leukaemia 
was preceded by a period of pancytopaenia, and all had been 
chronically exposed to high concentrations of adhesives, which 
contained 50% benzene (150 -  650 parts per m illion).O f the cases, 38% 
were acute myeloid leukaemia, compared with 16% of leukaemias in the 
non-exposed group of patients. Although the authors estimated the 
relative risk of leukaemia to be 2.2 between the exposed and control 
groups, the associated error in this value could be great owing to 
factors such as under-ascertainment of leukaemias in the exposed group 
(acknowledged by the authors), doubt regarding the basis for the 
authors’ general population rate, and the fact that the value was not 
age-adjusted. Furthermore, the pancytopaenia cases exposed to the 
’chronic’ /high exposures cannot be taken as typical of the total exposed 
population since these were affected individuals and their exposures 
were probably higher than average. Also it  is questionable that the 
author (Aksoy et al 1980) can be so precise about the quantitative 
estimates of exposure. Despite these weaknesses, the association 
between benzene exposure and acute myleoid leukaemia is strong.
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TABLE 2
THE EVALUATION OF LEUKAEMIA RISK IN EARLY 
EPIDEMIOLOGY STUDIES OF POPULATIONS
EXPOSED TO BENZENE
AUTHORS COUNTRY RELATIVE RISK OF 
LEUKAEMIA
Vigliani, 1976 Ita ly 20 times
Girard et a l., 1970 France ^Significantly greater
Aksoy et a l., 1980 Turkey More than double
Ishimaru et a l.,  1971 Japan 2 to 3 times greater
Infante et a l., 1977
>
U .S .A . 10 times greater
Statistically
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In  1976 Vigliani reported 11 cases of leukaemia at the Milan Institute  
which had occurred since 1942 whilst observing 66 patients with chronic
t
benzene poisoning. Most of the cases were from the prin ting  
industry. The benzene content of the inks and solvents was reported as 
being as high as 100%. Other cases from Pavia were observed, but 
the predominant source of exposure to benzene in this group was from 
shoe-making. Concentrations of benzene were found in the glues and 
solvents which were similar to those in the prin ting industry. 
Exposures to benzene were estimated to be in the region of 200-500 
parts per million. The author estimated that the incidence rate of acute 
leukaemia amongst workers heavily exposed to benzene was 20 times 
higher than that of the general population, although the documentation 
relating to this estimate is sparse.
Girard and Revol (1970) reported a hospital-based, case control study, 
in their evaluation of an association between benzene and leukaemia, 
and other haematological diseases. Amongst their 140 cases there were 
56 cases with myeloid leukaemia, and 61 cases with chronic lymphocytic 
leukaemia compared with 124 controls hospitalised for non-haematologieal 
conditions. In  this study exposure to benzene and toluene was
determined by questioning subjects about their exposure to chemicals in  
the 10 years prior to hospitalisation, and although benzene and toluene 
were clearly separated in ascertaining exposures, this was not 
continued in the presentation of the results in relation to the type of 
haematological disease outcome.
The exposure questionnaires were not conducted blindly and as a result 
there was the possibility of bias due to selective recall of exposure
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to benzene and/or toluene by the affected cases. This may have caused 
an over-estimate of the relative risk calculated. Nevertheless, the 
strong positive relationship between leukaemia and benzene was very  
evident, although owing to the lack of information on type and level of 
exposure, no estimate of dose response was possible.
A further example of the problems encountered in obtaining relevant 
and accurate data on benzene exposure is seen in the Ishimaru et al 
(1971) case control study of leukaemia in Nagasaki and Hiroshima. This 
study focused on occupational exposure to benzene and exposure to 
medical X -rays . In  all, 303 adult leukaemia cases were collected between 
1945 and 1967. Certain occupations were regarded as being
synonymous with benzene exposure. As a result, each occupation 
classified as having had potential benzene exposure may have included 
workers with no exposure to benzene, as well as workers with exposure 
to chemicals other than benzene. The relative risk of leukaemia was 
2.5 (95% Confidence Limit, 1 .3 -5 .0 ). However, the relative risks were 
not reported separately for potential benzene and medical X -ra y  
exposures and no attempt was made to quantify the risk of leukaemia in  
relation to intensity or duration of benzene exposure.
Thorpe (1974) conducted a mortality study among 38,000 employees, in  
eight European countries, of a large oil company. Exposures to 
benzene were classified according to whether the employees had been 
exposed to compounds with either more than 1% concentration of benzene 
or not.
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There are numerous limitations in the study such as the confidence that 
can be attributed to the reported standardised mortality ratios owing to 
the valid ity of the data on exposures, uncertainty as to the the age 
structure of the overall group of refinery workers, and the lack of 
documentation in identifying the leukaemia deaths. For those potentially 
exposed to benzene, the standardised mortality ratio was 121 (95% 
Confidence Limit, 37-205).
Infante et al (1977) reported some preliminary findings of a re tro ­
spective follow-up study of 1,006 employees involved in the manufacture 
of "rubber hydrochloride" (Pliofilm ). In  1981, Rinsky et al presented 
additional results on the same cohort. The exposure period was between 
1940 and 1949 and the authors were able to obtain historical quantita­
tive exposure data for this period. Although no additional leukaemias 
had been identified by Rinsky, follow-up was more complete than that 
reported by Infante et al (1977) and there was more detailed inform­
ation on the exposure estimates. The authors concluded that in general, 
employees1 8 hour time-weighted average exposure was within the 
recommended standard in effect at the time, (see Table 3 ). However, on 
further analysis of the data, there is some difficulty in ascertaining the 
exact level of exposure to benzene with which the excess leukaemias 
were associated. Although the authors believed that in general 
exposures did not "greatly exceed the current standard" concentrations 
of 10 parts per million, all the eight leukaemia cases in the cohort were 
associated with exposures to concentrations which were substantially 
higher than 10 parts per million. Of the eight cases, four were exposed
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TABLE 3
RECOMMENDED CONTROL VALUES OF BENZENE EXPRESSED AS 
PARTS PER MILLION (PPM) TIME WEIGHTED AVERAGE (TWA) 
OF BENZENE IN  THE UNITED STATES OF 
AMERICA BETWEEN 1941 AND 1969
YEAR CONTROL VALUE (PPM/TWA)
1941 100
1947 50
1948 35
1957 25
1963 25
1969 10
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TABLE 4
OBSERVED AND EXPECTED DEATHS FROM LEUKAEMIA IN 2 GROUPS
OF WORKERS IN RINSKY ET AL (1981) COHORT
STUDY
GROUP
NO. OBSERVED 
LEUKAEMIA 
DEATHS
EXPECTED TOTAL  
LEUKAEMIA DEATHS 
DEATHS
SMR
ALL
DEATHS
1: 748 7 1.25 180 111
2: 258 1 0.46 49 87
LEGEND
No.
SMR 
Group 1
Group 2
Number of Individuals in Group
Standardised Mortality Ratio
Individuals who had Worked for at Least 
1 day between 1:1:40 and 31:12:49.
Individuals who had Worked in a 
Department with Benzene Exposure 
between 1:1:50 and 31:12:59.
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prior to 1946 when exposures were unknown but the recommended 
standard was 100 parts per million and the remaining four were charact­
erised as having potential exposure for approximately 1.5 years to 
between 68 and 680 parts per million of benzene. Furthermore, there 
was the possibility of interm ittent exposure to concentrations in the 
region of 1,000 parts per million. Thus there is evidence that actual 
exposure levels may have been under-estimated. For reasons that are 
not clear, Rinsky et al (1981) studied the population in two groups, 
whereas Infante et al (1977) studied only one of the groups. The 
mortality experience of those exposed to benzene was compared with 
those of white males in the United States, white male fibrous glass 
workers in Ohio, and other workers at the study plants not thought to 
have had exposure to benzene. A summary of results from the Rinsky 
et al (1981) study are shown in Table 4. The standard mortality ratio  
for leukaemia in group 1 was 560 (95% Confidence Limit, 224-1154), 
compared to the general population figures. No detailed statistical data 
was given for individuals in group 2 other than a mention that the 
increase was not statistically significant.
Recently, Rinsky et al (1986) expanded the cohort to include a total of 
1,165 males which has resulted in six additional years of exposure being 
made available for fu rther analysis. In  this cohort, the total leukaemia 
deaths observed were 9 against 2.7 expected resulting in a standardised 
mortality ratio of 337 (95% Confidence Limit 154-641). These studies by  
Rinsky et al (1981, 1986), despite some of the limitations referred  to, is 
one of the firmest pieces of evidence linking excess leukaemia risk  to
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high levels of benzene exposure. In addition, it  raises the question of 
the importance of short term high peak exposures in addition to long 
term chronic exposure in the development of acute myeloid 
leukaemia as a result of benzene exposure.
Ott et al (1978), in their retrospective mortality study of a sub-cohort 
of 8,000 Dow Michigan employees, looked at 594 workers exposed to 
benzene in one of three production areas between 1940 and 1973. 
Exposures generally seemed to be relatively low, except for one 
production area, (35 parts per million time-weighted average), but 
again there is documentation which suggests that exposure was as high 
as 937 parts per million. The authors (O tt et al 1978) had calculated 
cumulative exposures for each member of the cohort. Although three 
leukaemias were found, only two were included in the mortality analysis 
as the th ird  died of bronchopneumonia with leukaemia listed as a 
contributory cause. All were of the myelocytic type. As the 
expected rate was based on incidence rates, it  may have been
reasonable to include the th ird  case in the analysis. It  is interesting
that all the leukaemia cases had relatively low cumulative benzene 
exposures, as compared with the main cohort. At the time, this 
indicated that benzene may have had a leukaemogenic effect at levels of
exposure previously considered safe. However, the study was
relatively small and, therefore, any estimate of the effect of benzene on 
the occurrence of leukaemia is probably imprecise. A lternatively, 
either the estimates of benzene exposure were optimistic or the 
leukaemias were not caused by benzene.
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Rushton and AldersonTs study (1981a) was a case control study within a 
larger cohort of eight refineries in the UK (Alderson and Rushton 
1981b). The number of leukaemia deaths was 36. There was no 
quantitative data on workplace benzene levels but an attempt was made 
to classify them into low, medium and high exposures based on work 
history records. The relative risk of the high and medium categories 
compared with the low category was 2.0 (95% Confidence Limits,
1 .0 -4 .0 ). There was no difference between the high and medium 
exposure categories. Although supportive of the leukaemogenic effect 
of benzene, the study is limited beeause of the lack of quantitative  
exposure data and the absence of any analysis by duration of exposure 
and time of firs t exposure.
Decouffle et al (1982) in their mortality study of 259 men in a chemical 
manufacturing plant where benzene had been used in large quantities, 
found three leukaemias. No quantitative exposure data were available 
and there was, in addition, the problem of mixed exposures to other 
chemicals. One of the deaths occurred after treatment with radiation  
and chemotherapy for multiple myeloma. It  is possible that this 
leukaemia resulted from such treatment, which is more probable than 
the speculation of the authors that benzene had a causal relationship 
with multiple myeloma.
Wong et al (1983) studied a cohort of 4,602 men from several chemical 
plants. Cumulative exposures to benzene were calculated by using 
length of employment and estimating 8 h r. time-weighted average for 
each job.
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A comparison cohort, forming an internal comparison group comprised 
3,074 men. The mortality rates were also compared with the national 
mortality statistics of the United States. There were 7 leukaemias 
observed in the exposed group and none in the non-exposed group. 
Expected figures were 6 and 3.4 respectively. There was no trend in  
the cell type in the excess leukaemias. The leukaemias occurred in 
individuals with relatively high exposures to benzene. None occurred 
with exposure at or below 10 parts per million time-weighted average. 
The surprising feature of this study is the deficit of leukaemias in the 
control group. In  addition, while overall mortality in occupational 
cohorts is usually below 100, the all cause mortality in the control 
group was relatively low, and low compared with the exposed group 
(standardised mortality ratio = 75, standardised mortality ratio = 87 
respectively). This is somewhat puzzling i f  both groups have the same 
selective features. For cancer deaths, the difference is even greater 
(standardised mortality ratio = 64, standardised mortality ratio = 102, 
respectively). In  general, malignant conditions have a less marked 
’healthy worker effect’ than other causes and with our present 
understanding of this phenomenon it  is difficult to see how this could 
apply to leukaemia. Although the most obvious reason for this 
apparent discrepancy is a failure to identify  deaths in the control 
group, there is absolutely no evidence of this nor is there any evidence 
of methodological inaccuracies.
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Tsai et al (1983) in their carefully conducted mortality study of 454 men 
in an oil refinery between 1952 and 1978, and exposed to low levels of 
benzene (median exposure 0.5 parts per million), found no leukaemia 
deaths. However, the study was small and only about a th ird  of the 
cohort had an adequate follow-up period.
Arp et al (1983), Checkoway et al (1984), and McMichael et al (1974) 
conducted case control studies of leukaemia and solvent exposure in the 
rubber industry. These studies were based on the same series of cases 
from one rubber company. Wolff et al 1981, included this series in 
addition to cases from three other companies. The study showed a 
positive association between lymphocytic leukaemia and solvents but in  
only one of the four companies. There was no association between other 
forms of leukaemia and exposure to solvents. Except in Checkoway’s 
study, where no distinction was made, exposure to benzene or 
benzene-containing solvents was categorised into primary and 
secondary. The former was related to workplace and task and the 
latter to workplace only. There were no quantitative data on benzene 
exposure. Although showing excess leukaemias, the relative risk  
estimates quoted in the studies had wide confidence limits, in addition 
to the problem of mixed exposures. I t  could be argued that the 
leukaemias found had as equal a chance of being caused by other 
solvents as by benzene.
Smith et al (1978) conducted a case control study of all male cases of 
acute non-lymphatic leukaemia seen at the University Hospital, Lund, 
between 1969 and May 1977. There were 50 cases. Three control 
groups were used for comparison.
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Although it  is not clear how the occupational categories were obtained, 
it  is presumed that this was by history. Of the acute non-lymphocytic 
leukaemia cases, 36% were occupationally exposed to "petroleum products 
or their combustion residues". Workers at filling stations, bus or 
truck drivers and operators of excavating machines were typical 
occupations. In  the control group for leukaemia deaths percentages 
were 10%, 14% and 0% respectively, and these control figures corres­
ponded to the expected values based on national statistics. There were 
no quantitative estimates of benzene exposure.
The epidemiological evidence linking exposure to high levels of benzene 
and the development of leukaemia, especially myelocytic, in humans is 
fa irly  convincing. However, quantitative estimates as to the magnitude 
of this association are d ifficu lt. In  assessing this association, some of 
the difficulties are inherent in the studies themselves with regard to 
design but in particular, measurements of benzene exposure for the 
relevant time periods of observation are inadequate in all of the studies 
reviewed. As a result, there continues to be much debate
surrounding the leukaemogenic effect of benzene at specific exposure 
levels and this is especially the case with regard to low levels of 
exposure. The la tter issue is an important one to consider, since low 
level exposures to benzene characterise many occupational settings in  
industry today and the resolution of this problem is not only of interest 
to regulatory bodies but also to the individuals who are occupationally 
exposed to benzene.
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From the epidemiological evidence, few would question that exposures to 
benzene above 100 parts per million time-weighted average carries a 
significant risk of developing leukaemia. However, for the studies 
involving lower exposure levels, the epidemiological evidence is not as 
convincing. Many risk assessments have been carried out, eg. White 
et al (1982), but inherent in these risk assessments lies the d ifficu lty  
in relying on epidemiological findings when the data on which they are 
based is usually sparse or imprecise. Furthermore, extrapolating effects 
at high levels to those experienced at low levels has the potential for 
gross inaccuracies. The human epidemiology data is insufficiently  
complete to describe accurately the dose response relationship with any 
degree of certainty. For benzene, the risk assessments have assumed 
that the leukaemogenic effect is directly proportional to cumulative 
exposure. This ’linear model’ is conservative in that it  probably  
over-estimates the leukaemogenic effect at low doses. Even i f  the 
latter hypothesis is not accepted, validation of a linear model with 
regard to the leukaemogenic effect of benzene has yet to be established 
and it  may be impossible to achieve this from the available 
epidemiological human data.
There is increasing evidence that the metabolism of chemicals such as 
benzene differs at low and high levels of exposure. High levels of 
exposure are associated with activating pathways of metabolism and 
saturation of detoxication mechanisms, so that it  is possible that there  
may be a benzene exposure level below which no leukaemogenic effect 
occurs, ie. a threshold may be present. In ter-and in tra-indiv idual
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variation may occur at many levels in relation to carcinogenic threshold. 
Pharmacokinetic, b io-availability, detoxification and repair mechanisms 
all interact with environmental, dietary and social factors. I f  this is the 
case, then the many risk assessments that have been carried out with 
regard to benzene may be unrealistic, especially when considering 
individual risk . As has been mentioned a fu rther problem which may 
confound some of the effects observed is that of interm ittent peak 
exposures, either in chronically exposed individuals or in individuals 
with no chronic exposure. Opinions d iffer regarding the importance of 
these exposures in relation to the toxic effects of benzene.
Van Raalte et al (1982) believe that peak exposures are more important 
that cumulative exposures. On the other hand, others suggest that 
there is some evidence that peak exposures do not have an independent 
effect on risk and are not over and above that associated with other 
exposure parameters eg. cumulative exposure. Nevertheless
intermittent peak exposures superimposed on chronic exposure is a 
phenomenon that is nearer the tru th  in most occupational settings \vhere 
benzene is present.
22
HUMAN GENOTOXICITY STUDIES
During the 1960's, there were several reports of increased rates of 
unstable and stable chromosome changes in lymphocytes and bone 
marrow cells of patients with benzene poisoning and in lymphocytes of 
workers with past exposure to benzene without signs of poisoning. It  
was also found that this damage from benzene could persist for years in  
long-lived lymphocytes and could perhaps result in the formation of 
abnormal cell clones in the absence of any signs of disease. Table 5 
summarises the studies described below.
Tough and Court Brown (1965) reported on chromosome aberrations in  
peripheral blood from 20 workers with 1-20 years of benzene exposure 
in a factory. For 2 years prior to the study, 14 of the men had 
exhibited neutropenia, the study having been performed two years after 
toluene had replaced benzene. The exposed workers exhibited an 
increase in lymphocytes with unstable and stable chromosome aberr­
ations but with statistical increases only in the former. Tough et al 
(1970) reported on the same 20 subjects, in addition to 12 workers from 
a similar factory with open vats of benzene, and 20 additional workers 
exposed to leaks from a closed distilling operation.
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Duration of exposure ranged from 1 to 25 years. At the time of 
analysis, 2-6 years had elapsed since cessation of benzene exposure, 
because of toluene substitution, in the vat operation, although in the 
distillation operation exposure to benzene was continuing. There was a 
significant increase in stable aberrations in the firs t group of 20 
subjects compared with both internal and general population controls. 
The group of twelve workers showed increased unstable chromosomal 
aberrations when compared with the general population but not when 
compared with controls from benzene-free areas of the factory. The 
distillation operation workers, on-site controls, and general population 
controls all had similar levels of chromosome aberrations.
The above were early studies, haematological data were lacking, and 
radiation was the only confounding variable considered. There was 
however a significant correlation between age and the number of 
aberrant cells but the data was not sufficient to assess whether there  
was a relationship between benzene exposure and the number of 
unstable chromosome aberrations.
Forni and Moreo (1969) reported a chromosome aberration pattern in a 
37 year old woman following seven years of exposure to benzene in  
excess of the threshold limit value in operation at the time. A 
pseudodiploid karyotype with a ring  and centric fragment was present 
in both bone marrow and peripheral blood cells and the authors in ferred  
that an abnormal stem cell had formed which could have resulted in the 
erythroleukaemic clone.
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Forni et al (1971a) reported increases in both stable and unstable 
chromosome aberrations in 100 peripheral blood lymphocytes from each 
of 32 manufacturing and maintenance workers with a history of 1 to 18 
years exposure to benzene. The 32 workers had a history of 
benzene-related clinical disease. Of these 25 had resolved
haemopathy, 4 had chronic haemopathy and 3 had acute poisoning. 
There were significant differences in the amount of stable and unstable 
chromosome aberrations between the haemopathy patients and the age 
and sex matched controls. However, there was no trend with respect to 
severity of haemopathy and frequency of cells with aberrations. In  
follow-up studies of 24 of the 32 subjects, unstable chromosome 
aberrations decreased in 13, slightly increased in 8 and were constant 
in 3 subjects. An abnormal clone was present in 3 cases. Aneuploidy 
was also increased compared with the matched controls. Although it  was 
stated that controls were examined for exposure to radiation, cytotoxic 
drugs, recent v ira l infections and vaccinations, it  is not clear i f  these 
factors were examined in the exposed workers. Smoking histories were 
not taken into account in either group.
Following an epidemic of benzene haemopathy in a rotogravure plant in  
1953 toluene was substituted for benzene. Benzene concentrations in  
workroom air ranged from 131 to 532 parts per million at the time of 
poisoning. Toluene exposures were measured as being in the region of 
200 parts per million.
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Forni et al (1971b) examined 100 cultured lymphocyte metaphases from 
each of 34 workers and 10 of these had pre-1953 exposure involving  
benzene. Health, age and sex-matched unexposed controls were 
obtained and people with a history of v ira l diseases or vaccinations 
were excluded from both groups. The benzene exposed workers (8 
with previous haemopathy) had significantly more unstable and stable 
chromosome aberrations than controls. Benzene workers also had 
significantly more aberrations compared to workers exposed to toluene. 
No relationship appeared to exist between years of exposure, age and 
chromosome changes. However, although these levels of exposure 
caused chromosome damage, three workers each with 3 years of benzene 
exposure and a history of leukopenia and a slight anaemia had normal 
cytogenetic values and two workers with long exposure but no history  
of haemopathy had abnormal values. This highlights either individual 
variability or possibly a chance finding.
Picciano (1979) compared 52 workers with one month to 26 years 
exposure to benzene (average 5 years) with 44 pre-employment 
controls. U rinary phenol levels, area monitoring and personal air 
sampling were used to estimate exposure. The exposure was reported  
as being 2.1 parts per million, time weighted average per worker over 
the 4 year period before the study and no increased urinary phenols 
were detected in the exposed. Each individual had 200 cells analysed 
and the average age of the controls was 26.6 years against the exposed 
39.3. Cells with marker chromosomes (rings, dicentrics, trans­
locations and exchange figures) and cells with breaks were more common 
in benzene-exposed workers than in controls.
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There was no relationship between age and chromosome damage. It  is 
unclear i f  smoking, recent illness, other clastogens, or other known 
confounding variables were excluded. Dabney (1981) has highlighted  
other factors which may have affected the apparent significance of the 
results, particularly the low incidence of aberrations in the controls. In  
a later analysis of the data Picciano (1980) reported a dose-related 
increase in aberrations when the exposed workers were divided into  
smaller groups by exposure (less than 1 parts per million to 2.5 parts 
per million and 2.5 parts per million to 10 parts per million). Dean 
(1985) suggests that since the small differences observed between the 
groups was confined to chromosome type aberrations and exchange 
configurations, the changes may have been caused by much earlier 
exposures to higher concentrations of benzene or other chemicals or 
x-irrad ia tion . Furthermore, Dean (1985) suggests that the control 
group was not adequately matched with the treated group.
Fredga et al. (1979) compared chromosome data from drivers of petrol 
road tankers, petrol station attendants, members of gasoline tankers  
and 12 industrial gasworks workers. It  was estimated that the industrial 
gas workers were exposed to between 5 and 10 parts per million 
benzene. Chromosome damage was significantly greater in the gasworks 
workers and petrol tanker drivers than in petrol attendants and crew 
members.
Watanabe(1980) investigated the effects of long-term benzene exposure 
on the incidence of sister chromatid exchange and structural 
chromosomal aberrations in 16 female workers who had been exposed to 
a maximum of 40 ppm benzene for between 1 and 20 years. Some of 
the exposed workers showed increased urinary phenol excretion.
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However, the cytogenetic study was conducted 6 months after benzene 
was eliminated from the work environment and at this time urinary  
phenol excretion was within the normal range. No increases in
chromosome damage were observed although there was a slight reduction 
in sister chromatid exchange by comparison with a matched control 
group of 7 females. The authors thought this might be due to a 
persistent effect of benzene on DNA replication.
Sarto et al (1984) examined peripheral blood lymphocytes from 22 
healthy workers from a benzene, toluene and xylene production factory. 
Exposures in 1980-81 were assessed from personal air samplers, expired  
alveolar air and urinary phenol and ranged from 0.2 to 12.4 parts per 
million time weighted average, bu t, exposures before 1971 were reported  
as higher. They were matched for absence of exposure to other geno- 
toxic agents, medical history, smoking habits, eating habits, recent 
vira l infection, number of X-rays in the preceding five years, drug  
consumption, incidence of familial spontaneous abortions, malformations 
and site of residence. The benzene workers were sub-divided into 2 
groups of high and low exposure levels supported by alveolar a ir, 
benzene concentrations and phenol excretion. There were no
significant increases in sister chomatid exchange observed between 
benzene exposed workers and their paired controls. There was a small 
increase in chromosome type aberrations in the benzene workers but not 
in chromatid type aberrations and the authors believed that this may 
have been a consequence of recent exposure to low concentrations of 
benzene or to exposure prior to 1971.
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Clare et al (1984) analysed chromosomes of peripheral blood lymphocytes 
from 10 workers after a single episode of high exposure to benzene. 
Workers on a single shift were exposed to high concentrations of 
benzene after a spillage of about 1200 tons of benzene during the 
loading of a ship. A substantial amount of phenol was excreted in the 
urine by the workers during the period following the spillage, 
indicative of high exposure. It  was 3 months after the spillage, that 
chromosomal analyses were carried out on the 10 men exposed and 11 
men employed on a comparable shift but who were not at work at the 
time of the spillage. There was no significant difference in the 
incidence of aberrations between the two groups although there was a 
non-significant increase in the sister chromatid exchange values of the 
benzene-exposed group.
In addition to the above, extensive reviews have been conducted by  
Dean (1978) Health & Safety Executive (1982) Van Raalte et al (1982) 
and Dean (1985b).
GENOTOXICITY STUDIES
In  an attempt to examine how benzene exerts its carcinogenic effects, 
various genotoxicity parameters have been investigated.
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Microbial System s
Benzene has been investigated in Salmonella typhimurium in many 
laboratories in the Ames tester strains. Using the plate incorporation 
assay and a metabolising system derived from Aroclor-induced rat liver, 
benzene has given negative results (Lebowitz et al (1979), Drevon et al 
(1980), Mueller (1980), Shimizu et al (1983)). In  the international 
collaborative study (Ashby and de Serres et al 1985) there are 5 
reports of benzene where plate incorporation and pre-incubation  
protocols have been used. The five standard tester strains TA1535, 
TA1537, TA1538, TA98 and TA100 and TA97 and TA102 and a forward  
mutation assay with strain TM677 (Vennitt 1985) all gave negative 
responses. With the more sensitive fluctation assay, (McCarroll et al 
1980)a positive response was detected in TA100 strain in the presence 
of Aroclor-induced rat liver enzymes and there was a differential killing  
in the repair proficient and deficient strains of Escherichia coli 
(McCarroll et al 1981 a ,b ) .  A similar result was found in B subtilis as 
well as in another strain of E Coli assay (Rosenkrantz et al 1980). In  
the International Collaborative Study (Ashby and de Serres et al 1985) 
negative results were obtained for gene conversion and mitotic 
recombination of yeast (P arry  1985) but a weak positive result for gene 
mutation and aneuploidy was also found in D6 strains of 
Saccharomyces cerevisiae (P arry  1985). Thus in summary, the
majority of results are negative in microbial assays.
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Plant System s
Schairer et al (1982) showed that benzene produced somatic cell 
mutations in filamentous stamen hairs of Tradescantia after exposure to 
benzene vapour.
Insect Systems
Benzene added to the medium in which larvae of Drosphila melanogaster 
were grown, showed no increases in mutations to eye pigmentation. 
There were no sex-linked recessive lethal mutations, heritable 
translocations and crossing-over in adult Drosophila males after 
treatment v/ith benzene vapour, even though doses producing high
toxicity were used. However, benzene produced sperm at o gonial
crossing-over although there were no changes in the spermatocytes 
(Kale et al 1983). In the International Collaborative Study (Ashby and 
de Serres et al 1985), 3 investigators tested benzene. Wurgler et al 
(1985) observed wing spot changes in an assay responding to 
chromosomal breakage, deletions and aneuploidy, mutations and mitotic 
recombination, but Vogel et al (1985) and Fujikawa et al (1985) 
recorded equivocal and negative results respectively in an eye-spot
assay to detect gene mutation and deletions. Lyang et al (1983) showed
mitotic arrest, multi-polar spindles and chromosome lagging in mitosis 
after benzene treatment of grasshopper (Melanoplus sanguinipes).
Thus it  appears that benzene is capable of producing genetic effects 
through chromosome disturbances as opposed to gene changes.
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Cultured Mammalian Cell System s
Unscheduled DNA Synthesis
No unscheduled D N A . synthesis as determined by autoradiography 
was detected in three studies with benzene using prim ary rat 
hepatocytes, (Probst et al 1981, Williams et al 1985, Probst et al 
1985) nor was it  detected in Hela cells using a liquid scintillation 
technique (Martin et al 1985, B arrett 1985). However, (Glauert et 
al 1985) did detect an increase in primary rat hepatocytes using 
s cintillation countin g .
Gene Mutation Systems
In the International Collaborative Study (Ashby and de Serres et 
al 1985) 15 separate studies were carried out. Of these 7 were at 
the thymidine kinase locus and one at the ouabain locus in L5178Y 
mouse lymphoma cells, 3 at the hypoxanthine guanine 
phosphoribosyl transferase locus in Chinese hamster V79 lung  
cells, others of resistance to 6 thioguanine and ouabain in Chinese 
hamster ovary cells, and the thymidine kinase and hypoxanthine 
guanine phosphori-bosyl transferase loci in human lymphoblasts. 
There were 6 positive reports at the thymidine kinase, 
hypoxanthine guanine phosphoribosyl transferase or ouabain loci 
but Garner (1985) concluded that there was no convincing evidence 
of mutagenicity.
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Sister Chromatid Exchange Studies
Gerner-Smidt and Friedrich (1978) and Morimoto and Wolff (1983) 
showed that benzene failed to induce sister chromatid exchange in 
lymphocyte cultures in the absence of an exogenous metabolising 
system (S 9). Later Morimoto et al (1983) produced sister
chromatid exchange in lymphocytes in the presence of ra t liver S9
fraction which could be abolished by glutathione. In  the
International Collaborative Study (Ashby and de Serres et al 
1985), benzene failed to induce sister chromatid exchange in 5 
studies using Chinene hamster ovary and V79 lung cells with and 
without S9 and in RL4 rat liver cells (Dean 1985a).
Metaphase Chromosome Studies
Early studies with benzene showed little  or no induction of 
chromosome damage (Dean 1978). In  the International Collaborative 
Study (Ashby and de Serres et al 1985) three investigators 
detected the induction of chromosome breakage following benzene 
exposure while 5 did not (Dean 1985b). The positive results were 
only obtained in those studies which took account of mitotic delay. 
Howard et al (1985) detected chromosome aberrations in 72 hr  
human lymphocyte cultures in the presence and absence of S9 mix 
when treated for a 3 h r period 44 hrs after culture initiation. 
Danford (1985) showed an induction of aneupolidy in Chinese
hamster liver cell cultures but there was no increase in poly-ploidy  
in cultured cells.
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Cell Transformation Studies
Benzene was tested by Amacher and Zelljadt (1983) in Syrian 
hamster embryo system increasing the incidence of cell clones with 
the morphology of chemically-induced neoplastic transformation. 
In the International Collaborative Study (Ashby and de Serres et 
al 1985) 2 separate studies produced positive results in SHE cells 
(McGregor et al 1985). In  the mouse fibroblast cells (B alb/c 3T3) 
and the enhancement of a v ira l (SA7) transformation in Syrian 
hamster embryo cells, benzene was negative. Only the SHE systems 
are comprised of primary cultures of embryonic material which 
retain endogenous metabolising enzymes.
Recently cell culture systems have been identified as potentially 
very useful experimental models for the quantitative measurements 
of the activity of carcinogens and tumour promoters (B arre tt et al 
1984.) The use of cell transformation assays in the study of 
chemical carcinogenesis allows an analysis of the cellular events in 
neoplastic progression, independent of certain host effects, such 
as immunological surveillance, and cell tissue interaction.
The C3H10T£ mouse fibroblasts line, isolated in 1973, has been 
extensively studied and reported on, particularly in the last 5 
years. This assay has largely superseded earlier in  v itro  
transformation work with C3H prostate fibroblasts (Chen and 
Heidelberger, 1969). C3H10T£ cells with a sub-tetraploid
chromosome mode are very strongly contact-inhibited.
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Although morphological transformation of C3H10T£ cells has been 
reported following exposure to polycylic aromatic hydrocarbons and 
their derivatives, to pyrimidines, hair dye components, cigarette 
smoke condensate, chemotherapeutic agents, metal compounds, and 
certain physical agents, several classes of known or suspected 
carcinogens do not induce positive responses in the standard assay 
as described by Reznikoff et al 1973. For example, the capacity 
of the standard assay system to identify  direct acting alkylating  
agents as carcinogens was shown to be severely limited. Cyclo­
phosphamide, aflatoxin B l,  dimethylnitrosamine, and 
2-acetylamino-fluorene also give negative responses in the standard 
assay.
The discovery of a two-stage requirement for transformation of 
C3H10T! cells (Mondal et al 1975) has opened up a new field of 
study into the identification and mode of action of in itiating and 
promoting agents (Mondal & Heidelberger 1980), co-carcinogens 
(Nesnow et al 1981) and synergistic phenomena (Mondal et al
1977). Enhanced foci formation was reported when cells exposed to 
either chemical or physical initiators were subsequently treated  
with a potent tumour promoter 12-0-tetradecanoylphorbol-13- 
acetate. In  the C3H10T£ test system incorporating the la tter 
treatment regime, Boreiko et al (1982) have shown that aflatoxin 
B l and the direct acting nitrosamide N -m ethyl-N -n itroso-N -n itro - 
guanidine act as in itiating agents. Formaldehyde was also shown to 
have similar properties.
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Carcinogenic potency is regarded as a complex function of 
in itiating and promoting activ ity . The C3H10T£ assay has shown 
promise in identifying and discriminating between these activities 
in respect of individual chemical carcinogens and in complex 
mixtures such as mineral oils (A Wright, personal communication). 
Only one study has been reported in the case of benzene (Amacher 
& Zelljadt 1983) where various chemicals reportedly non-mutagenic 
to Salmonella typhimurium in Syrian hamster embryo cell 
transformation studies were tested. One transformed colony was 
noted in the case of benzene indicating a positive result. However, 
there are no published reports of classical initiation and promotion 
experiments using C3H10T£ cells with benzene.
The evidence for the genotoxicity of benzene is substantial as 
suggested by its ability to induce sister chromatid exchange and 
chromosomal aberrations. By adopting molecular dosimetry 
techniques, it  theoretically could be possible to identify  and 
quantify these interactions with DNA.
Cultured Cell Studies
Procter et al (1986) have pointed out that benzene does not react 
with culture medium either with or without foetal calf serum but its  
volatility even in closed vials is so great that 90% of a 250 parts  
per million solution is lost to the head space after 1 h r at 24°C. 
They stress the importance of ensuring that maximum solubilization 
and minimal volitisation of benzene during exposure are essential 
for obtaining reproducible data on the mutagenic potential of 
benzene.
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Cytogenetic Studies in -vivo
Animals dosed intraperitoneally or subcutaneously with benzene 
produced increased chromosome damage in bone marrow cells (Dean
1978). Mice exposed by inhalation (3100 parts per million for 4 hrs) 
showed a doubling of sister chromatid exchange compared with 
untreated mice (Tice et al 1979), but at the same exposure there was 
no chromosome damage. However, pre-treatm ent with phenobarbital 
(50 m g/kg twice daily for 3 days) before benzene treatment, caused 
bone marrow cell depletion in males and an increase in chromosome 
aberrations in both sexes but more so in males. Pre-treatment with 
phenobarbital, compared with benzene alone, caused an increase in  
sister chromatid exchange in females but not in males. Tice et al 
(1980) suggested that different metabolites of benzene may be 
responsible for the absence of a relationship between cell proliferation  
sister chromatid exchange and chromosome aberrations.
Tice et al (1981) exposed 2 strains of mice of different ages to 
inhalation of benzene (28-3000 parts per million) and another strain was 
dosed intraperitoneally. A fter 4 hrs exposure to benzene at 28 parts  
per million there was a significant increase in sister chromatid 
exchange. Sister chromatid exchange induction was influenced by  
variables such as sex, strain, age, pre-treatm ent and route of 
exposure.
Inhalation exposure was about 10-fold more effective in inducing sister 
chromatid exchange than was intraperitoneally dosing. The authors also 
suggested that the liver may not be the main site for the metabolism of
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benzene to genotoxic metabolites as partial hepatectomy did not alter the 
frequency of sister chromatid exchange induced by exposure to 3000 
parts per million benzene for 4 hrs (Tice et al 1982).When benzene- 
exposed mice were simultaneously given an intraperitoneal injection of 
toluene, sister chromatid exchange incidence was markedly reduced, 
confirming that toluene was a competitive inhibitor of benzene 
metabolism (Sato et al 1979).
Siou et al (1984) administered benzene by oral intubation to mice at 2 
doses ranging from 0.1 to 2.5 m l/per kg , at 24 hour intervals. 
Chromosome damage and micronuclei counts in polychro-matic 
erythrocytes were increased and male mice were shown to be twice as 
sensitive as females to benzene. Castrated males were shown to have 
the same sensitivity as females and castrated males given testosterone 
showed a similar response to uncastrated males. Sexually inactive mice 
showed no sex difference in response to benzene. The finding that 
males were more sensitive than females was later confirmed by  
Gad-El-Karim et al (1984) in mice exposed to benzene at daily oral 
doses for 2 successive days or intraperitoneal doses of 440 m g/kg.
Diaz et al (1980) and Hite et al (1980) examined micronuclei in 
polychromatic erythrocytes in mice after oral doses of benzene for 2 
days, 24 hours apart using a dose range up to 2.0 m l/kg.
Micronuclei were scored at either 6 or 30 hr after the second dose with 
the highest incidence of micronuclei at 30 hrs. Increases were seen at 
6, 18 and 24 hours and after 5 days at higher daily doses, but by 9 or
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16 days the numbers of micronucleated cells had returned to control 
levels. Meyne and Legator (1980) compared oral and intraperitoneal 
dosing with benzene on the induction of micronuclei and chromosome 
aberrations. Benzene in corn oil was administered at doses of 0 .1 , 0.5 
and 1.0 m l/kg. on each of 3 successive days. Cells were harvested 4 
hours after the final dose. The induction of metaphase aberrations 
was independent of the root of administration, but oral dosing was more 
effective than intraperitoneal injection in micronuclei induction and males 
were also more sensitive than females to benzene.
Mice exposed for 9 days to 10,' 25, 100 or 400 parts per million benzene 
showed a dose-related increase in micronuclei, determined 24 hours 
after exposure (Tice et al 1984). In a fu rther study where mice were 
exposed to 300 ppm of benzene for up to 16 weeks and sampled from 3 
days to 16 weeks there was reduced clastogenicity with increasing 
period of benzene exposure. However, Luke et al (1985) found no 
alteration in micronuclei induction with time, although sex and strain  
differences were observed when mice were exposed to 300 parts per 
million for 3 hours a day for three or five days per week. They 
postulated that perhaps a tolerance was developing in the form of an 
adaptive response. In  a long-term bioassay (National Toxicology 
Programme, 1985) there was some evidence of a reduction in a 
clastogenic response in micronuclei from normochromatic erythrocytes  
after 103 weeks of oral dosing of benzene at 50 or 100 m g/kg.
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V/hen sister chromatid exchange in blood lymphocytes were compared 
with micronuclei in bone marrow polychromatic erythocytes of male mice 
after inhalation exposure to benzene at nominal concentrations of 0, 10, 
100 or 1000 parts per million benzene for 6 h r , at 18 hr sampling, both 
parameters were increased thereby giving similar results. Erexon et al
(1984) and Erexon et al (1985) exposed human peripheral blood 
lymphocytes to a number of known and suspected benzene metabolites in  
vitro  and found dose-dependent increases in sister chromatid exchange, 
decreases in mitotic indices and inhibition of cell cycle kinetics.
A study where bone marrow cells from CDl-mice and Sprague Dawley 
rats were analysed following inhalation of 1,10,30 and 300 parts per 
million benzene for 6 hrs /day 5 days/week for a total of 13 weeks 
showed that, at values below 30 parts per million, there were no 
significant increases in chromosome aberrations compared with control 
values in either rodent other than at the top dose value.
Styles and Richardson (1984) showed dose-related increases in  
metaphase aberrations in bone marrow cells in rats after 6 hours 
exposure to benzene at dose levels of 1,10,100 or 1000 parts per 
million.
Styles and Richardson (1984) found that repeated exposure of benzene 
over 5 days did not increase the frequency of chromosomal aberrations 
above that following a single exposure but the frequency after 6 h r  
inhalation was significantly higher than that after 2 h r exposure to the 
same concentration.
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Dean (1985) suggests that repeated exposure of rats to benzene induces 
enzyme systems that reduce the generation of clastogenic metabolites. It  
may be that more severely damaged cells are eliminated from the cycling 
cell population. In  contrast Luke et al (1985) showed that repeated 
inhalation exposure of mice to benzene did not lead to a reduction in 
micronuclei response.
Molecular Dosimetry
Molecular dosimetry is a relatively new approach for the assessment of 
genotoxicity and is based on measuring the products of interaction of 
chemicals with DNA.
The somatic mutation theory of cancer indicates that cancer is 
associated with genetic damage induced by chemicals or viruses. 
Mutations resulting from covalent interactions of chemicals with DNA 
may be an important in itial stage in chemical carcinogenesis. There is 
now considerable evidence which has established that many carcinogens 
or their metabolites covalently bind to DNA in vivo with the formation 
of DNA adducts. The formation of DNA adducts by indirect
mechanisms can also occur with some carcinogens (Barrows & Shank 
1981). Other alterations in DNA such as strand breakage, gene 
rearrangement or gene amplification may also be important stages in 
carcinogenesis. However, the covalent binding of chemicals to DNA 
appears to be the significant in itiating event which can lead to 
secondary genomic alterations unless the carcinogen adduct is repaired.
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Hence it  is widely accepted that any chemical which forms covalent 
bonds with the DNA of somatic and reproductive cells in vivo should be 
viewed as a potential mutagen, carcinogen, or teratogen (Randerath et 
al 1985).
Studies on the binding of chemicals to DNA and the mechanisms of 
formation of DNA adducts are therefore important in the identification of 
potential carcinogens. In  terms of risk assessment, a major research 
objective is to determine the qualitative and quantitative relationship 
between the formation of DNA adducts and the resulting lesions in  
target tissue. Much of the present knowledge on the interaction
between benzene and cellular macromolecules has been obtained by the 
use of isotopically labelled benzene.
Lutz & Schlatter (1977) showed that radioactivity was associated with
the DNA after exposure to tritia ted benzene. In  addition they also
14showed low level of radioactivity after treatment with C labelled 
benzene. Although tritia ted benzene enabled a higher sensitivity, 
exchange reactions complicate the interpretation of their results.
14Arfellini (1985) also showed evidence of covalent binding of C labelled 
benzene. However, this was of a low order of magnitude. None of 
these experiments provide definitive evidence of covalent interaction  
with DNA owing to the fact that adducts were neither detected nor 
identified. Thus, probably owing to insufficient labelling and 
subsequent failure to hydrolyse the isolated DNA and quantify the 
adducts, the ability of benzene or its metabolites to covalently interact 
with DNA to form adducts remains controversial. What can be said,
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14however, is that from evidence with C-benzene, any interaction is 
probably of a low order of magnitude.
Recently, Snyder et al (1987) has conducted experiments with benzene 
in mitochondria and investigated the formation of DNA adducts. The 
rationale for such studies was the observation by Kalf et al (1982) that 
rats treated with benzene led to inhibition of mitochondrial RNA 
synthesis. Rushmore et al (1984) later found that benzene metabolites 
covalently bound to mitoplasts (mitochondria with their outer membrane 
removed) DNA. These recent in vitro  experiments by Snyder suggest 
that DNA adduct formation occurs with benzene in mitochondria. The 
structure of the adduct seems to be the result of interaction between 
p-benzoquinone or hydroquinone with one or more DNA bases.
The application of molecular dosimetry techniques is limited to those
compounds which may be synthesized readily in radio-labelled form and
the specific radioactivity achievable determines the limit of detection of
adducts in vivo. Studies in humans using these methods are not
possible. As a result alternative methods for studying interactions of
carcinogens with DNA which do not re ly  on radio-labelled carcinogens
have been developed. At the forefront of such methods for detection of
DNA adducts formed from non-radiolabelled compounds are
immunochemical assays and post-radiolabelling. The incorporation of
32high specific radioactivity in the form of P into DNA adducts has thus 
found widest application in the latter technique, and has recently been 
extensively reviewed by Watson (1987).
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ANIMAL CARCINOGENICITY STUDIES
Early attempts to discover a benzene-leukaemia animal model were 
unsuccessful. In  1980, Snyder et al exposed groups of 50 AKR/J and 40 
C57B1/6J male mice to 100 parts per million and 300 parts per million of 
benzene for 6 h r/d ay , 5 days per week, for life . The former strain  
carries a virus that produces a high incidence of thymic lymphoma and 
the latter a virus that produces lymphoma only after exposure to 
external agents. Both strains developed persistent lymphocytopenia and 
anaemia after the firs t week of benzene exposure. The survival time of 
C57B1/6J was decreased but not that of AKR/J mice. Significant bone 
marow hypoplasia developed in the AKR/J mice treated with 100 parts  
per million benzene. When compared with an earlier study of Snyder, 
the effect appeared to be dose-related. In the C57B1/6J mice there was 
an increase in the incidence of haemopoietic neoplasms and thymic 
lymphomas and in comparison with controls there was a reduced 
induction time.
Snyder et al (1982) exposed male C D -I to 300 parts per million for 6 
h r/d ay  5 days-week for 222 days and found a 50% decrease in survival. 
Bone marrow hypoplasia and anaemia and lymphocytopaenia and 
haemopoietic neoplasms developed one week after benzene exposure. 
Goldstein and Snyder (1982) and Goldstein et al (1982) reviewed these 
findings and described the firs t reported cases of the induction of 
myelogenous leukaemia in rodents by benzene. In  40 C D -I mice exposed 
to benzene at 300 parts per million there was one acute myelogenous 
leukaemia, one chronic myelogenous leukaemia and one granulocytic
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hyperplasia. There was also one case of chronic myelogenous leukaemia 
observed in one of 40 Sprague-Dawley rats exposed to 100 parts per 
million benzene. Although the results were not statistically significant 
their uniqueness indicated a direct effect of benzene inhalation when 
compared with the absence of such leukaemias in earlier animal 
experiments.
Maltoni et al (1982) believed, however,that the control groups in  
Goldstein et al’s studies (1982) were too small, that the use of histor­
ical controls could not be applied satisfactorily for small differences, 
and that myeloid leukaemia was not exceptional in Maltoni1 s studies. He 
analysed the carcinogenic potential of benzene in Sprague Dawley rats 
given by stomach tube at 50 or 250 mg/kg or by inhalation at 200 parts 
per million 4 h r/d ay  5 days/week to pregnant rats from the 12th day of 
pregnancy until delivery. Offspring were exposed to inhalation of 
200-300 parts per million benzene 4-7 h r/d ay  5 days/week for 15 or 144 
weeks and then observed for their lifetime. Zymbal gland carcinomas 
were measured in both male and female rats and there was a small 
incidence of other tumours (tumours in the the liver and oral c a v ity ), 
including mammary carcinomas, .  Due to the ra rity  of the tumours and 
the presence of solid tumours, the author suggested that benzene may 
be a multipotential carcinogen (Maltoni et al 1983). I t  is of in terest, 
that it  was Maltoni and Scarnato (1979) that claimed the firs t 
experimentally induced carcinoigenic effects of benzene.
Cronkite et al (1984a) confirmed the findings of Goldstein et al (1982) 
on benzene-induced lymphoma-leukaemia in female C57B1/6 mice. The 
mice were exposed to 300 parts per million for 6 h r/d a y , 5 days/week 
for 16 weeks and were observed during their lifetime. By week 64, 1 of
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88 controls, 10 of 90 exposed mice, had died. Of the 10 that died, 6 
had thymic lymphoma and 2 had an unspecified lymphoma. There were 
no leukaemias in the control group. The authors suggested that this 16 
week exposure, which was sufficient to cause a major pertubation to the 
bone marrow, was a better experimental system to study 
benzene-induced leukaemo gene sis than the lifetime exposure regime used 
by Synder et al (1982). Cronkite et al (1984b) also described the effect 
of benzene-exposure on marrow cellularity and its relationship to 
lymphoma induction.
Similar effects to those of Maltoni were reported in a 2 year National 
Toxicology Programme Study (1985) with F344/N rats and B6C3F^ mice 
where benzene was administered by oral gavage in corn oil for 5 
days/week for 103 weeks. Mice of both sexes were dosed with 0,25,50  
or 100 m g/kg benzene and male rats with 0,50,100 or 200 m g/kg and 
female rats with 25,50 and 100 m g/kg. A dose-related decrease in  body 
weights and survival, as well as an increase in malignant lymphomas 
was evident in all treated animals. Female mice were more sensitive to 
treatment than male mice. A significant increase in Zymbal gland 
carcinomas was seen in mid dosed and high dosed male rats and mice, 
in all dose groups of female rats , and in high dose female mice. 
There was an increase in the incidence of tumours of the skin, in  
squamous cell papillomas and carcinomas of the skin of males only, and 
cancers of the oral cavity in rats treated with high doses. 
Benzene-related effects were also seen in the lungs, Harderian gland, 
preputial gland, ovaries, mammary glands, forestomach and adrenals in  
mice but not in rats.
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ANIMAL HAEMATOLOGY STUDIES
Many groups have investigated blood changes in animals exposed to 
benzene. Deichmann et al (1962) found that leukopaenia was evident in  
the rat after 1 week exposure to benzene at doses of 600 and 1300 
parts per million for 5 hours/day, 4 days a week for 3 months, and at 
lower levels within 3-5 weeks. Nau et al (1966) described similar 
findings. Green et al (1981) observed a dose-related increase in  
leukopaenia in C D -I mice exposed to benzene at doses of 1 to 4862 
parts per million for 6 h r/d ay  for 5 days. At exposures of 103 parts 
per million and above, there was a reduction in the number of 
granulocytes and lymphocytes and the cellularity of the marrow and 
spleen was depressed.
Cronkite et al (1982) studied the effects of inhaled benzene on the bone 
marrow stem cells of mice using the tTspleen colony forming un it” 
technique. Spleen colony forming units result when bone marrow cells 
of donor mice are administered intravenously to irradiated recipient 
mice. Colonies are observed on the surface of the spleen after bone 
marrow cells from the donor mice migrate to the spleen of the recipient 
mice and grow into colonies, and indicate the number of stem cells from 
the donor animals that were administered to the irradiated recipient 
animals.
Male BNL donor mice were exposed to 400 parts per million benzene for 
6 h r/d ay  5 days/week for up to 9£ weeks. Benzene caused a significant 
decrease in both red and white peripheral blood cell counts throughout
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the exposure period. A three-fold decrease in marrow cellularity and a 
five-fold decrease in colony forming unit content was observed after 5 
days exposure to benzene. The colony forming units undergoing DNA 
synthesis were also decreased. The authors attributed the marrow 
cellularity decrease to a reduction in erythrocytic and granulocytic 
precursors.
Toft et al (1982) recorded the number of nucleated cells and 
colony-forming granulopoietic stem cells in the bone marrow following 
inhalation exposure of male NMR1 mice to inhalation of benzene at 
concentrations of 1 to 200 parts per million. The frequency of 
micronuclei in polychromatic erythrocytes was increased by exposure to 
20 parts per million continuously for 4-10 days or to 20 parts per 
million for 8 h r/d ay  for 5 days /week for 2 weeks. A similar observation 
was made by Tunek et a l(1981,1982) following subcutaneous injection of 
mice with benzene and its metabolites, hydroquinone and catechol. 
Benzene at 440 m g/kg severely reduced cellularity and the number of 
colony-forming stem cells.
Baarson et al (1984) studied the effect of ethanol ingestion on benzene. 
Male C57B1/6J mice were exposed to 300 parts per million benzene 6 h r /  
day 5 days /week for 3 weeks. During this time they were given 5 or 15% 
ethanol in the drinking water which was freely available. Peripheral 
blood erythrocytes and lymphocytes were depressed in all groups 
treated with benzene. Red blood cell counts were depressed more in the
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benzene-treated and ethanol-treated animals. Generally lymphocytopaenia 
in benzene /ethanol treated mice was greater than, or equal to, that in  
mice treated with benzene alone. Ethanol had no effect on peripheral 
blood cells. A transient increase in nucleated red cells in the peripheral 
blood was observed in the ethanol-treated animals. Alterations in cell 
morphology were greatest in animals treated both with ethanol and 
benzene. The authors concluded that ingested ethanol enhanced the 
haematoxicity of benzene. Driscoll and Snyder (1984) showed that 
alcohol-treated mice eliminated benzene more rapidly than alcohol-free 
animals but after 4 weeks there was no discernible difference between 
the elimination of the two groups. Baarson et al (1984) exposed 
C57B1/6J mice to 10 parts per million of benzene for 6 h r/d a y  5 
days/week and caused a significant progressive depression of the 
in vitro  colony forming ability of the erythroid progenator cells as 
measured by colony forming units. Benzene exposure produced a 
decrease in splenic nucleated red cells, circulating red blood cells and 
lymphocytes. Bone marrow and splenic progenitor cells exhibited a 
decrease in their ability to form colonies in benzene treated animals. 
The numbers of colony forming units from benzene exposed mice 
reached 5% of control for marrow cells and 10% for spleen cells. Benzene 
exposed mice also exhibited a significant decrease in the numbers of 
differentiated haemaopoietic cells including circulating red blood cells 
and lymphocyte. The blood lymphocytes were depressed at all times 
but benzene appeared to have no effect on peripheral blood neutrophils. 
The authors concluded the colony forming units had a progressive 
inability to replicate and differentiate in culture and that low levels of 
benzene considered occupationally safe in humans could markedly 
disrupt normal erythropoieses in mice.
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Male C57BL/6J mice exposed to inhaled benzene at 10, 30, 100 and 300 
parts per million for 6 hours per day for 6 days exhibited significant 
depression in blastogenesis in T and B lymphocytes (Rosen et al, 
1984). There was a decrease in both phytohaemagluttinin-induced 
splenic mitogenesis and lipopolysaccharide-induced B cell mitogenesis. 
Benzene did not effect splenic T cell numbers. Peripheral blood 
lymphocyte counts were depressed at all benzene levels, and red blood 
cell counts were depressed only at the highest levels . Short-term  
exposures to inhaled benzene at low exposure levels caused significant 
decreases in both lymphocyte number and function.
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BIOCHEMISTRY
I t  is worth considering in some detail, the metabolism of benzene and 
the possible mechanism by which it  may exert its genotoxic effects.
Although the bioactivation of benzene is complex, it  is now accepted 
that benzene requires metabolism to exert its toxic effects. Phenol is 
formed by the oxidation of benzene in the liver by the cytochrome P450 
system (Gonasun et al 1973). The principal secondary metabolites of 
benzene, namely,hydroquinone and catechol are also formed in the 
liver; the former by hydroxylation of phenol and the la tter by 
hydrogenation of benzene dihydrodiol (Jerina et al 1968, Tunek et al 
1980).
Suppression of cell growth and function in  bone marrow and the 
lymphoid system correlates with the concentrations of hydroquinone and
catechol which accumulate in the bone marrow and lymphoid tissue
following exposure to benzene (Greenlee et al 1981, Wierda et al 1982). 
Latriano et al (1986) has shown that the formation of muconaldehyde, an 
open-ring metabolite, occurs in mouse liver microsomes, in addition to 
aromatic metabolites, and this compound has been shown to be a potent 
toxin to the blood (Witz et al 1985). Although the bone marrow
possesses a limited capacity to metabolise benzene, it  seems insufficient 
to account for the concentration of benzene metabolites occurring in this 
tissue (Irons et al 1980). Phenol, however, is readily metabolized in 
bone marrow (Sawahata et al 1985). Nevertheless the relative
contribution of each of these pathways in the induction of bone marrow 
toxicity following benzene exposure remains unclear, but the quinone
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metabolites of benzene have proven to be toxic to bone marrow and 
lymphoid cells both in vivo and in vitro  (Irons et al 1981, Pfeifer et al 
1981,1982). Quinones are formed by the oxidation of hydroquinone or 
catechol. Hydroquinone is then oxidised spontaneously under 
physiological conditions in v itro  to form p-benzoquinone, forming 
p-semiquinone intermediate in the reaction (Greenlee et al 1981b). Irons
(1985) has recently reviewed the current understanding of the 
disposition and bioactivation of benzene, as summarised in f ig . l .
Putative hypotheses regarding the mechanisms of benzene toxicity  
include free radical formation via superoxide, covalent binding of the 
semi-quinones to DNA, RNA or other cellular macromolecules, or 
alternatively, direct alkylation of sulphydryl groups by p-benzoquinone 
or its ortho-hydroxy derivative. Studies conducted by Irons et al
(1984) have indicated that the la tter mechanism may predominantly be 
responsible for suppression of cell growth associated with hydroquinone 
and parabenzoquinone.
Benzene metabolites have been shown to affect both the bone marrow 
and lymphoid cells of ra ts , in vivo and in v itro  including reduction in  
cellu larity, suppression of lymphocyte function and sister chromatid 
exchanges (Morimotto and Wolff 1980). The significance of these 
alterations with respect to bone marrow damage or leukaemo gene sis is 
unclear; however, potent suppression of cell growth blastogenesis by  
these compounds indicate that this mechanism is of importance with 
respect to bone marrow and lymphoid suppression, and aplastic anaemia. 
Phenol, hydroquinone and catechol suppress cell growth in rats in  v iv o . 
Neither phenol nor catechol suppress lymphocyte growth or function at
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LEGEND -  FIGURE 1
Schematic diagram of the known and proposed metabollism for 
benzene. The figure is a modified and composite representation of 
the metabolic pathways for benzene as reported by Irons et al 
(1981) and Erexon et al (1985).
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concentrations that do not result in  cell death. However, hydro- 
quinones suppress mitogen-induced lymphocyte blastogenesis at 
relatively low concentrations, and p-benzoquinone is approximately twice 
as potent as hydroquinone (Irons, Irons and Pfeifer 1981, 1982, 1983).
Irons et al (1983) and Irons (1985) have shown that the effect of 
benzene metabolites such as p-benzoquinone and hydroquinone is 
sulphydryl-group (SH)-dependent and can be protected against by the 
addition of low molecular weight SH compounds, eg. 2-mercapto-ethanol 
or dithiothreitol. Furthermore, similar experiments using SH compounds 
indicate that suppression of blastogenesis involves internal cellular SH 
groups critical for lymphocyte blastogenesis. Irons (1985) stated that 
the most likely explanation of these findings involves the SH alkylating  
properties of compounds such as p-benzoquinone. Previous studies have 
revealed that exposure to benzene in vivo is associated with an arrest 
of already proliferating bone marrow cells (Muirhead et al 1980). This 
cell cycle arrest together with the apparent SH cell activ ity  of 
p-benzoquinone and hydroquinone has led Irons to examine tubulin as a 
potential macro-molecular target for these compounds. Irons (1985) 
examined the role of quinones as toxic metabolites of benzene and 
referred to microtubule in tegrity  as a factor required, not only for 
spindle formation and division, but also for regulation, surface receptor 
movement and normal signal transduction of the cell surface. 
Consequently they have concluded that the possible mode of action of 
some of the metabolites of benzene is by in terfering  with microtubule 
function and, consequently, microtubule-dependent processes such as 
blastogenesis, secretion and cell division (Irons et al 1984).
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The cytoskeleton has been implicated as being an important structure  
for early events associated with promotion (Pfeifer and Irons 1981). The 
effects of low concentrations of benzene metabolities in lectin-stimulated 
lymphocytes resemble those induced by established promoters such as 
12-0-tetradecanoyl phorbol 13-acetate, indicating a possibility that these 
compounds may alter lymphocyte differentiation by similar mechanisms. 
A correlation between the ability of phorbol esters to act as co-mitogens 
to phytohaemagluttinin-stimulated lymphocyte cultures and their tumour 
promoting ability has previously been demonstrated (Touraine et al 
1977).This co-mitogenic enhancement of lymphocyte growth response by 
benzene metabolites may explain the seemingly anomalous hypoplastic 
responses observed in bone marrow of animals and man following 
exposure to benzene and it  suggests that these agents may be of 
primary importance with regard to the disruption of growth control on 
differentiating bone marrow cell populations. Although possibly not the 
only mechanism operating in benzene leukaemo gene sis, the evidence for 
promotional activity from these experiments should be considered 
further in suitable experimental models (see cell transformation 
studies).
SYNOPSIS OF EXPERIMENTAL WORK
The refinery where the present study has been conducted was included 
in the Rushton and Alderson epidemiology studies (1984b). No excess 
of leukaemia or other malignancy was identified with benzene exposure 
in the cohort that had been investigated. Records and personal 
communication suggested that potential benzene exposure had shown a 
downward trend with time, in line with control limits and improved plant
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design and work practices. Accidental spillages occurred, and a 
genotoxicity study had been performed in 1981 by Clare and the author 
of this present study in an attempt to quantify such high, short-term  
exposures in terms of sister chromatid exchange and chromosome 
aberration induction. The latter study (Clare et al_ 1984), in addition 
to the debate surrounding the presence, magnitude and effects of 
confounding factors on the genotoxic effects in humans from current 
potential benzene exposures at the Refinery, prompted this present 
study.
The present study examines genetic, kinetic, haematological and 
biochemical parameters in the peripheral blood from 66 employees 
compared to 33 on-site controls. These individuals were sampled at an 
oil refinery in 1984 and were exposed to low levels of benzene. An 
attempt has been made to take into account various known social 
confounding variables.
Furthermore, the effects on lymphocyte proliferation described by Irons
(1985) was investigated in the lymphocytes of the same population 
undergoing the cytogenetic investigation.
Furthermore, experiments to investigate the possible mechanisms of 
benzene genotoxicity and carcinogenicity were performed. Molecular 
dosimetry techniques were employed to ascertain the amount of 
interaction between benzene and DNA. Cell transformation studies were 
carried out with benzene to investigate aspects of initiation and 
promotion.
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CHAPTER 2
HUMAN GENETIC STUDIEStf' ------- - ------------------------------------
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INTRODUCTION
As described in Chapter 1 human studies investigating the effects of 
occupational benzene exposure on the incidence of chromosome 
abberations and sister chromatid exchange at levels between 1-10 parts  
per million have been inconclusive.
Animal data indicate that there are measurable effects at doses as low 
as 1 part per million. The difficulties surrounding the interpretation of 
human studies have related to methodological considerations, eg. use of 
different culture techniques, reagents, adequate consideration of 
confounding variables, bias in scoring and the absence of adequate 
quantitative exposure data.
This study was controlled in that all reagents for genotoxic and kinetic 
analysis were purchased as one batch prior to the start of the study.
The effects, described by Irons (1985), on the proliferation of 
lymphocytes of rodents exposed to various benzene metabolites have not 
been investigated in human lymphocytes of a population occupationally 
exposed to benzene. By employing the technique of mitogen-induced 
blastogenesis, the present or absences of these effects were 
investigated in this study.
Finally, the mutagenicity of urine was examined as an additional end­
point which has been employed to measure occupational exposure to 
genotoxic agents.
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The above study was supplemented by urinary  phenol estimations, as a 
biological monitor for benzene exposure, and by routine haematology 
and biochemistry investigation of the peripheral blood.
MATERIALS AND METHODS
Population Selection
S ixty-six males with low average exposure to benzene and th irty -th re e  
control males were investigated. The s ixty-s ix  men worked in jobs 
where benzene or material containing benzene was handled, and all had 
been potentially exposed to benzene for periods in excess of five years. 
Three main work areas were identified, ie . shipping, oil movements and 
aromatics production. Exposures in the present study were assumed 
to be of the same order as those of previous personal and work-place 
air samples taken from individuals in similar jobs collected over a period 
of years. The data are classified in Table 6, according to shift time 
weighted average (TWA) and level (time unspecified). Some of the 
jobs, eg. loading and unloading of benzene on the je tty , have strict 
requirements for the wearing of protective breathing apparatus. In  
other areas the wearing of respiratory protection is variable. The 
controls were selected from the refinery population based on evidence of 
presumed non-exposure to known genotoxic agents. A detailed 
questionnaire on health status and social habits was compiled for each 
individual. (Appendix 1) One individual refused to complete the 
questionnaire.
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LEGEND -  TABLE 6
Exposure TWA Long Term: Exposure represented by breathing zone
concentration of benzene expressed in  
parts per million (ppm) over an 8-hour 
shift (TWA -  time weighted average). 
Two categories -  1.5 ppm and <lppm.
Exposure TWA Sometime: Exposures represented by breathing zone 
concentrations of benzene expressed in  
parts per million (ppm) averaged over an 
8-hour shift (TWA-time weighted average) 
which were experienced by individuals at 
sometime during the period of exposure 
monitoring. Two categories -  5-10ppm 
and l-5ppm .
Level Sometime: Exposures expressed as parts per million 
as a non-averaged level and represented  
by breathing zone concentrations of 
benzene lasting for any time during a 
sh ift.
Pygas:
Mo gas:
Benzene-Stream
Approximately 30% benzene. 
Approximately 1.5% benzene. 
30% -  100% benzene.
The Table was constructed by examining the exposure pattern of the 
individuals in the same job e .g . ,  of the 16 Shipping Operators in 
Figure 6, all had evidence of exposures at ’sometime’ to between 
5-10ppm TWA of benzene and all had been exposed to a level of benzene 
’sometime’ in excess of lOOppm. However, during normal operations the 
routine exposure of two individuals was between l-5ppm  TWA and the 
other 14 individuals was <lppm TWA.
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Figure 2 illustrates the population in terms of age, and Figure 3 the 
distribution of smoking, drinking, exposure to diagnostic ionising 
radiation and v ira l infection (referred  collectively as ’life style’ 
factors). Table 7 summarises the individuals categorised by age, 
tobacco smoking and drinking habits.
Blood Sampling
Blood samples were obtained from a maximum of 8 individuals per week, 
over a thirteen week period, so that a total of 99 individuals were 
sampled. Wherever possible a mixed number of controls and exposed 
individuals were selected for each batch. Collection was between 9.00 
and 10.30 a.m.
Blood Sample Collection and Storage Prior to Processing
For each individual approximately 65 ml of blood was withdrawn by  
venepuncture. A single drop of blood was placed on each of two 
microscope slides and smeared for differential white blood cell 
count. One ml of blood was transferred to a sequestrene tube 
for total red blood cell and white blood cell counts, haemoglobin, 
packed cell volume and mean corpuscular volume determinations. 
For chromosome aberrations and sister chromatid exchange analyses 
5 ml of blood was transferred to another sequestrene tube. For 
serum biochemistry analysis, 10 ml blood was transferred to an 
ethylenediamine-tetracetic acid (EDTA) tube. The remainder of 
the blood was equally distributed between three sterilised, 
silicone-coated, glass MacCartney bottles each containing 0.4 ml
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LEGEND -  FIGURE 2
Age distribution of individuals in the exposed and control groups 
that were included in this present study. The matching in the 
age range 35 -  39 and 40 -  44 was unequal and resulted from the 
anomaly which existed at the site in relation to these particular 
age ranges.
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LEGEND -  FIGURE 3
SMOKING CATEGORY: NON :
EX : 
CU :
DRINKING CATEGORY: NON :
SOC : 
REG :
X-RAY EXPOSURE: YES :
NO :
VIRUS INFECTIONS: YES :
NO :
Non-Smoker -  never smoked more
than occasionally
Ex-Smoker -  stopped >3 months
ago
C urrent -  1 or more cigars,
Smoker cigarettes, or
pipe per day.
Non-Drinker -  <2 units/week. 
Social D r i . -  2/20 units/week. 
Regular D ri-  >20 units/week.
During last 12 months.
None during last 12 months.
During last 6 months.
None during last 6 months.
(Viruses defined as 
Glandular Fever, Measles, 
Flu, Chicken Pox, Mumps, 
Common Cold, O th er).
r iu  o . DISTRIBUTION OF
SMOKING/DRINKING/X-RAY EXPOSURE/VIRAL INFECTION
IN STUDY POPULATION
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LEGEND -  TABLE 7
D rinking Category
Smoking Category
Non-Drinker 
+ Social Drinker
++ Heavy D rinker
Non Non-Smoker 
Ex Ex-Smoker 
Cu Current Smoker
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of 2,500 jig/ml sodium heparin in 0.9% saline. The sequestrene 
tube and MacCartney bottles were inverted a few times to 
thoroughly mix the blood with anti-coagulant. The blood smears 
were fixed in methanol for 20 min before overnight storage.
In itia l processing of blood samples
Blood samples were processed on the same day of collection 
starting between 4 and 5 p.m .
Materials
Bottles and other glassware were purchased from Fisons Scientific 
Loughborough. Plasticware from Sterilin, Teddington except cryotubes 
(Nunc, Gibco Uxbridge) .Ilacon disc cutter harvester, Ilacon Cambridge, 
Scintillation m ixture, 4g of 2,5 diphenyloxizole per litre  AR toluene -  
Fisons Scientific, Loughborough.
For the sister chromatid exchange and chromosome aberration 
experiments, culture medium (Eagles minimal essential medium -  EMEM), 
penicillin, streptomycin and L-glutamine were supplied by GIBCO, 
Uxbridge. Foetal calf serum (FCS) by Sera-lab, Crawley, Sussex, 
lymphoprep TM by Nyegaard, Norway, bromodeoxyuridine 5mM in  
phosphate buffered saline -  solution type A, demecolcine and 
bisbenzimide 5 jjg/ml in purified water by Sigma Chemicals, Poole, 
Dorset. Mitogens for chromotome aberrations and sister chromatid
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exchange (Phytohaemagluttinin reagent grade) and mitogen-induced 
blastogenesis (Phytohaemagluttinin purified grade) which was recon­
stituted in phosphate buffered saline solution type A was supplied by
3
Wellcome Diagnostics D artford. H -thymidine was supplied in an 
aqueous solution 5.0 Ci/mmol, (lm Ci/m l) by Amersham International 
Amersham.
Mitogen-Induced Blastogenesis
The sodium heparin blood sample (3x10ml)
(MacCartney bottles) were processed as follows:
1. An equal volume of phosphate buffered saline was added without
2 + +Ca & Mg (10 ml) to the blood in each universal bottle.
2. The blood was thoroughly mixed in each universal bottle by
pipetting and layered onto 10 ml of proprietary lymphocyte 
separation solution in a 50 ml centrifuge tube.
3. Centrifugation was carried out at 800g (at the interface of the
fluids) for 20 min at 20° C in Coolspin centrifuge with
brake rate set at minimum.
4. The mononuclear cell layers were transferred (with platelets) from
the three tubes to a single, fresh 50ml centrifuge tube.
5. 25 ml of phosphate buffered saline solution type A was added and
mixed by drawing up and down in a Pasteur pipette.
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6 . The latter was centrifuged 250g (at base of tube) for 10 mins at 
20°C or room temperature; with minimum braking at the end of 
spinning.
7. A sample was taken from the middle of the supernanant and
introduced into the haemocytometer chamber and checked to see 
that there were no more than 1 x 10 cells/ml present. I f  there
were more cells, step 6 was repeated until the number of cells in
the supernanant was decreased below this level.
8 . All but about 1 ml of the supernanant was withdrawn, the cell 
pellet being broken and suspended in solution using a Pasteur 
pipette.
9. Steps 5-8 were repeated inclusively, with the exception that the 
checking procedure was omitted after the second wash.
10. Eagle’s minimum essential medium with antibiotics was added, plus
15% foetal calf serum (EMEM-15) to a volume approximately equal to
the original volume of blood, ie. 30 ml.
11. The suspension was repeatedly mixed by Pasteur pipetting, 0.2 ml 
of this suspension was diluted in 19.8 ml of Isoton &/or 0.4 ml in  
19.6 ml of same. 4-6 drops of Zap-0-globin was added to each 
dilution white blood count density determined by performing  
Coulter counts according to Standard Operating Procedures.
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12. Where necessary the cell suspension was concentrated to more than
g
1.3 x 10 white blood cells /ml and after centrifugation at 350g for 
10 min at 20°C or room temperature with minimum braking, Coulter 
counting was repeated.
0
13. A cell suspension (2 .5  ml) containing 1.33 x 10 wbc/ml in 
EMEM-15 was then prepared.
14. Aliquots of 75jil of the prepared cell suspension in Step 11 were 
distributed into each of 24 U-wells of a microtitre plate.
15. Eagles minimal essential medium (25|il) was added containing 
phytohaemagluttinin purified grade of varying concentrations to 
each U-well to give triplicate microcultures for each of following 
treatments -  10, 5 ,1 ,0 .5 , 0.25, 0 .1 ,0 .05  ug/ml phytohaemogluttinin 
purified grade and phytohaemagluttinin purified grade vehicle for 
46 to 48 hrs.
3
16. A fter removal from the incubator H-thymidine was added to each
microculture to give l|iC i /ml. The microcultures were
reincubated for 18 hours and then harvested onto GF/C filte r discs 
using an Ilacon disc cutter harvester. The dried discs were 
counted for their tritium content in diphenyloxazole/toluene 
scintillation mixture, quench correction being made by the external 
standard method.
69
Storage of Prepared Lymphocytes for any Further
Additional Studies
All cell suspensions remaining after the setting up of 
phytohaemogluttinin purified grade-dosed microcultures were 
distributed into 5 ml cryotubes and 10% dimethylsulphoxide added 
with immediate mixing. The cryotubes were labelled and then 
well-wrapped in tissue or kitchen roll before being tightly  packed 
into small polystyrene boxes. To freeze down the cells the boxes 
were kept at approximately -20°C overnight and then at -70°C for 
at least 6 h r . Finally, and as quickly as possible, the cryotubes 
were unpacked, fitted onto ampoule canes and transferred to liquid  
nitrogen storage.
Preparation of Chromosomes for Chromosome Aberration Analysis
For each blood sample, a 0.8 ml volume of freshly remixed blood was 
added to each of two plastic universal bottles containing 10 ml of 
Eagles’ minimum essential medium. Cells were sedimented by
centrifugation (170g.5 m in). The supernantant was withdrawn and 
discarded and the cell pellet, approximate volume 0.5 ml. disrupted and 
re-suspended in 9.5 ml of Eagles minimal essential medium supplemented 
with 15% foetal calf serum. Reconstituted phytohaemagluttinin reagent 
grade (lOOjil) was added per culture immediately priot to incubation at 
37 ± 0.5°C in humidified 5.0 ± 0.1% CO^ in a ir. A fter 48 hr 50 pi of 
10 jag/ml demecolcine (g iving 0.05 ug/ml of culture medium) was added 
per culture. A fter 2 hr reincubation cells were harvested by centri­
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fugation, swelled in 0.075 M KC1 and fixed in 3:1 v /v  methanol, acetic 
acid. Chromosome spreads were prepared by the air drying techniques 
and stained with Giemsa.
Preparation of Chromosomes for Sister Chromatid Exchange Analysis
As for the conventional chromosome preparations cells from each of 
duplicate 0 .8  ml volumes of each blood sample were washed with 10 ml 
of Eagles minimal essential medium and resuspended in 9.5 ml of Eagles 
minimal essential medium supplemented w ith  15% foetal calf serum. 
Reconstituted phytohaemagluttinin reagent grade (100 pi) and 50 pi of 
5mM 5-Bromodeoxyuridine were added per culture just prior to 
incubation at 37 ± 0.5°C  in humidified 5.0 ± 0.1% COg in a ir. A fter 70 
hr 50 pi of 10 pg/ml demecolcine was added per culture. A fter 2 hr 
reincubation, cells were harvested by centrifugation, swollen in  0.075 M 
KC1 and fixed in 3:1 methanol, acetic acid. Chromosome spreads were 
prepared by the air drying technique and chromatids differentially  
stained by a fluorescent plus Giemsa method modified from Perry and 
Wolff (1974). Cells were protected from light at all times after the 
addition of BrdUrd until harvested.
Staining Reagents
Phosphate buffered saline solution type A without calcium and 
magnesium, Giemsa stain (G u rr’s ), G urr’s buffer (pH 6 . 8 ) and G urrTs 
DePex was suplied by BDH Poole.
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Sister Chromatid Exchange Staining
The sister chromatid exchange slides were immersed in 5 ug/ml 
bisbenzimide, thoroughly wetting the slides by agitation from side 
to side and lifting  up and down. The slides were then left 10 
minutes and removed from the solution and rinsed by a gentle flow 
of water. The slides were placed faced up in a shallow tray  and 
covered with phosphate buffered saline and exposed to 254nm UV 
for 1 hour. The slides were then placed in a rack and rinsed as 
before in  water. The slides were stained in 5% Giemsa (350ml 
buffer + 17.5 ml Giemsa) for 5 min. The slides were thoroughly 
rinsed with flowing tap water and brie fly  in distilled water in a 
staining dish. The slides were laid out and excess water removed 
by careful dabbing with tissues. The slides were left to dry  
completely and once differential staining was confirmed to be 
satisfactory under the microscope, the preparations were mounted 
in DePex under 22 x 50 mm coverslips.
Chromosome Staining
Giemsa (17.5 ml) was added to 330 ml of bu ffer in  a staining dish. 
The chromosome preparations were placed in a rack and then 
placed in the stain and moved from side to side with up and down 
movement to ensure a thorough wetting of the slides before mixing 
of the staining solution. The slides were then left for 5 min. 
They were then thoroughly rinsed with a gentle flow of water from 
a tap hose and then finally rinsed in distilled water in a staining 
dish. A fter confirming satisfactory staining under the microscope 
the preparations were mounted in a similar fashion to the sister 
chromotid exchange preparations.
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Slide Scoring
Proliferative Rate Index
As a measure of cell cycle kinetics, the proliferative rate index  
was measured for each sister chromatid exchange slide. This was 
accomplished by measuring the number of different metaphase 
divisions observed on slides prepared for sister chromatid 
exchange studies (see photographic plates 1,2 and 3 ). The 
proliferative rate index was calculated by substituting the values 
for the number of cells in 1st, 2nd and 3rd metaphase based upon 
their d ifferential staining with bromodeoxyuridine into the formula. 
PRI = 1(M I) + 2 (M2) + 3(M3)
100
Where (M l = 1st Metaphase)
(M2 = 2nd Metaphase)
(M3 = 3rd Metaphase)
High values of proliferative rate index are indicative of a high rate  
of proliferation.
Sister Chromatid Exchange
The preparations were coded by a responsible individual not 
involved in the scoring. The data recorded on each slide was 
covered using sticky-backed labels. The code was unique to each 
set of slides. Where possible the firs t 25 consecutive well-spread  
second cycle metaphases from each set of slides was counted.
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PHOTOGRAPHIC LEGEND -  1, 2 and 3
Ml Cell at firs t metaphase after one complete cycle of DNA
replication in the presence of 5-bromodeoxyuridine. DNA 
of both chromatids is un ifiliary  substituted with
5-bromodeoxyuridine and shows intense staining with 
Giemsa.
M2 Cell at second metaphase after 2 complete cycles of DNA
replication in the presence of 5-bromodeoxyuridine. The 
DNA of one chromatid of each chromosome is un ifiliary  
substituted with 5-bromodeoxyuridine and shows intense 
staining with Giemsa. The DNA of sister chromatid is 
bifilia ry  substituted with 5-bromodeoxyuridine and shows 
pale staining with Giemsa. Sister chromatid exchanges 
can be seen as crossover points in the staining 
characteristics of the chromosome.
M3 Cell at th ird  metaphase after 3 complete cycles of DNA
replication in the presence of 5-bromodeoxyuridine. On 
average half of the chromosomes appear with both 
chromatids showing pale staining with Giemsa. The 
remaining chromosomes have one pale and one intensely 
staining chromatid. The actual number of each kind in 
an individual cell is dependent on the orientation of 
the dark and light chromatids at the metaphase following 
the second replication cycle.

The cells counted were taken from two or more duplicate slides of 
each set. The metaphase had to have 45 or more centromeres 
before it  was scored. The co-ordinates of the cell were recorded 
together with the number of sister chromatid exchanges; also 
details of any aberrations to the normal chromosome complement 
were noted. The information was recorded on sister chromatid 
exchange analysis raw data sheets. Two scorers were involved, 
significant scoring differences having been resolved prior to the 
procedure.
Chromosome Aberrations
The preparations were coded by a responsible individual not 
involved in the scoring of the chromosomal aberrations. The 
information recorded in each line was obscured using sticky-backed  
labels and the unique code designated for each set of slides was 
printed 011 the label. Each metaphase was recorded under oil 
immersion and the vern ier readings noted. For each metaphase 
two main recordings were made, the firs t was the centromere 
number; i f  the metaphase contained 45 or more centromeres the 
number of centromeres and any aberrations were recorded. 
Secondly, the presence and type of aberration was recorded. The 
aberrations were coded according to the United Kingdom 
Environmental Mutagenesis Society (UKEMS) Sub-Committee 
Guidelines as shown overleaf, and subsequently analysed 
statistically using the categories shown overleaf.
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/
UKEMS Description ^Statistical Analysis
g C hro m atid  gap C hrom atid  D e le t io n s
c C hrom atid  b re a k  ” ”
f  C hrom atid  fragm ent ,T "
G Chromosome gap Chromosome D e le t io n s
C Chromosome fragm ent 11 "
F Chromosome fragm ent w ,T
M M in u te  ” 11
c /c  C hrom atid  exchange C hrom atid  Exchange
D D ic e n t r ic  Chromosome Exchange
R R in g  O th er
X M u l t ip le  a b e r ra t io n s  O th e r
NOTE: UKEMS United Kingdom Environmental Mutagenesis Society
Classification Category
* Categories used for statistical analysis
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Urine Sample Collection
Urine samples were collected in polythene or polypropylene containers 
from 30 controls in the morning and on successive weeks and were 
stored frozen at -20°C .
Urinary Phenol
Urine for urinary  phenol estimation was processed as described by  
Baldwin et al 1981 measuring total urinary phenol by hydrolysis of the 
conjugates. Analysis was by gas liquid chromatography and flame 
ionization. (Hewlitt Packard, GLC 5703A). The results were then 
standardised to a urine specific gravity of 1024.
Ames Test on Urine Samples
Materials
The Ames test experiments used the strains of Salmonella 
typhimurium TA 98 and TA 100 from Dr Bruce Ames, University  
of California, Berkeley. Beta- glucuronidase/sulphatase, 
di-methylsulphoxide (DMSO), benzo(a)pyrene, NADP and glucose
6-phosphate from Sigma Chemicals, Poole, Dorset. 2-Nitrofluorene  
Cambrian Chemical Co. Bio Beads from Bio-Rad Labs, 
Connecticut, USA. Aroclor from Monsanto Chemicals, St. Louis, 
Vogel Bonner Medium from Lab M, Salford, Lancs and potassium & 
magnesium chlorides from BDH Chemicals, (Poole).
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Beta-glucuronidase/sulphatase Treatment
The urine samples were thawed and were vacuum filtered through 
a Whatman N o .l filte r into sterile containers. To the filtra te  was 
then added sufficient bet a-glucuronidase/ sulphatase to give a final 
concentration of 65 units/m l. The pH of the mixture was adjusted 
to 7.4 with either sodium hydroxide 0.5m or hydrochloric acid 
0.5m. This mixture was then incubated in the dark for 24 hours 
before being concentrated.
Urine Concentration
Pre-packed Bio-Beads SM-2 ’Econo-column' were rinsed with sterile 
filtered water. The urine samples were then loaded onto the 
column (a 20 ml syringe facilitating column loading) and allowed to 
pass through, without pressure, at a rate of about 2-3 ml / min, 
the rate being regulated by means of a stopcock. All operations 
were at room temperature. This was then followed by 2 mis of 
water. The eluate was discarded, and the columns dried, as 
much as possible, with negative pressure applied to the bottom of 
the column.
The retained material from the urine was then eluted with 20 mis 
of Analar grade ethanol into a sterile vessel and evaporated to 
dryness under a nitrogen stream at 50°C. A fter complete drying , 
the concentrated residues were then made up to 1 / 100 th of the 
original volume with dimethylsulphoxide (spectrophometric grade) 
immediately before testing.
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Metabolic Activation Mixture (S-9 M ixture)
Male Sprague Dawley rats , 180-200g, were given a single 
intra-peritoneal injection of Aroclor 1254 at 500 m g/kg. A fter 3 
days, the rats were fasted overnight, killed by cervical dislocation 
and the livers homogenized (1 g liver : 3 mis Tris / KC1 buffer  
pH 7 .4 ). The homogenate was centrifuged for 20 minutes at 
9,000 g and the supernatant dispensed into 5 ml vials for freezing  
in liquid nitrogen. A single batch of S9 was prepared and prior 
to testing was checked for its ability to activate a mutagen by  
using benzo(a)pyrene with strain TA 1538.Immediately prior to the 
assay, the S9 mixture was made in a solution containing the 
following:
NADP (4mM), glucose 6 -phosphate (5mM) KC1 (33mM) MgCl^ ( 8mM) 
and phosphate bu ffer, (O.lmM -  p H 7 .0 ).
During each Ames test benzo(a)pyrene was used as a positive 
control both for the viability of the S9 and the mutability of the 
strains.
Bacterial Culture
The histidine-dependent strains of Salmonella typhimurium  
described as TA98 and TA100 were used in this particular Ames 
test assay. The bacterial strains having been thawed from liquid  
nitrogen storage were grown overnight (approx. 16 hrs) in a 25% 
nutrient broth solution water bath for the whole period. The 
broth cultures were stored at 4°C until they were required.
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Preliminary Testing
Before commencing the assay the cultures were checked for their 
various characteristics and their response to known mutagens.
Sensitivity to Mutagens
The reversion characteristic of both strains were checked using 
known mutagens as follows:
For TA98, 2-nitrofluorene without S9 activation was used and for 
TA100 methyl nitro nitrosoguanidine (MNNG) without S9 activation 
and benzo(a)pyrene 5 jig/plate with S9 activation.
( 2-nitrofluorene and methyl nitrosoguanidine were tested by 
placing a small amount in the centre of the a plate containing the 
relevant tester s tra in ).
Deep-Rough Characteristics
Both strains were checked for sensitivity to crystal violet to
confirm the presence of the deep-rough characteristic. This
characteristic confers a "leaky,T coat in the bacterium allowing 
large molecules to enter. I t  also prevents the bacterium from 
being pathogenic.
Plasmid
Both strains were checked for resistance to ampicillin as an
indicator of the presence of the plasmid.
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Test Procedure
The appropriate number of tubes were prepared containing 2 mis of top 
agar (0.6% agar with 0.5% sodium chloride with histidine 50 jxM and 
biotin 50 jiM ), to which was added 0.1 ml on the tester strain, the 
relevant quantity of the urine concentrate and S9 mix. All the 
samples in this study received S-9 mix owing to the low volume obtained 
from the subjects thereby putting a restriction on the number of tests. 
The resultant mixture was then poured directly on to the plates 
containing Vogal Bonner E Medium and incubated in darkness at 37°C 
for 3 days.
The resulting colonies were then counted with an automatic colony 
counter and the plates evaluated visually for a background lawn of 
growth.
Haematology
Materials
Isoton I I  and Zap-0-globin, Coulter Electronics, Luton. 
May-Grunwald and G urr’s improved Giemsa from BDH (Poole). At 
between 8.00 and 9.00 am on the morning after collection the 
sequestrene tubes were equilibrated at room temperature and then 
mixed on a blood cell suspension mixer for approximately 10 
minutes. An initial 1:500 dilution in Isoton I I  was made with a 
Coulter Dual D iluter I I I  for white blood count and haemoglobin 
determination. A fu rther dilution to 1 ; 50,000 was made for the 
red blood count and mean and packed cell volume determinations.
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Haemoglobin and white blood cell dilutions were haemolysed with 
Zap-o-globin. Counts were made using a Coulter 2F6 system, at 
appro-priate aperture settings, following calibration with a Coulter 
4c standard. Blood films were stained with May-Grunwald and 
Giemsa and 200 white blood cells were counted per blood sample at 
550 x magnification.
Blood Biochemistry
Biochemistry values for uric acid, creatinine, glucose, urea, gamma 
glutamyl transpeptidase, serum glutamate oxaloacetate transaminase, 
serum glutamate pyruvate transaminase, triglycerides and cholesterol 
were obtained for each using standard Boehringer reagents on a Hitachi 
705 analyser.
Statistical Analysis
The maximum mitogenic response -(maximum response values from the 
mitogen induced blastogenesis d a ta ), proliferative rate index (P R I) , 
sister chromatid exchange (SCE), mean corpuscular volume (M C V ), and 
urinary phenol (UP) were analysed separately. Individuals from whom 
data were not available or for whom the response was zero were 
excluded from the analysis of that particular variable. The individuals 
were sorted on the basis of their responses to the questionnaire.
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The more information obtained from the individuals the more the groups 
were divided with the formation of unique sub-groups. This resulted in  
the possibility that the effects of one factor may confound the effects of 
another complicating the interpretation. The data were entered into a 
GEC4190 computer using the Minitab (Ryan, Joiner & Ryan 1976)
statistical package. Data were subsequently analysed using various 
procedures contained in the Minitab package including one-way analysis 
of variance and step-wise multiple linear regression.
One-way analysis of variance is a statistical method which compares the
variation observed between groups of individuals with the variation  
within the groups. The statistical test is carried out by comparing a
value, F, which measures the ratio of between-group to within-group
variation, with tabulated values. I f  the value of F obtained from the 
test is higher than those in the appropriate tables a statistically  
significant result has been found. Subsequently fu rther testing
between the group means can be carried out. In  the case of two
groups the one-way analysis of variance is equivalent to the two-sample 
pooled t-te s t. The assumptions behind both the t-tes t and the
analysis of variance are the same, namely that the values within each 
group are independent of each other and are normally distributed with 
equal variances within each group. In  the case of the data here these 
assumptions are not necessarily met. In  particular, the association of 
certain life-sty le  factors with one group of individuals rather than  
another could produce a confounding effect in the results. This occurs
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when it  is not clear which one or more factors results in an effect on 
the biological measurements. Further details of the theory and the 
procedures for calculating the statistics of the analysis of variance are 
given by Snedecor & Cochran (1967).
Stepwise multiple linear regression analysis is an extension of the 
analysis of variance methodology to explore the simultaneous effects of a 
series of different variables on a particular variate. In  this procedure 
an attempt is made to relate a single dependent variate e .g . a maximum 
response to a linear function of several independent variables such as 
the life-sty le  factors. There are a number of different algorithms which 
can be used to produce the regression equation. The method used 
here chooses the variable which ’explains1 the most variation in the 
dependent variate. The remaining variables are then tested against the 
dependent variate ’corrected’ for the fitted  variable and the next best 
’explanatory’ variable added to the regression equation. This
procedure continues until no fu rther variables remain to be fitted  or 
alternatively no variables reach a pre-determined level of significance in  
the analysis of variance. (A full description of the methods and a 
discussion of the issues involved in multiple linear regression can be 
found in Draper & Smith 1968). A measure of the overall effectiveness 
of the multiple regression is the multiple correlation coefficient R 
Square, which is an estimate of the proportion of the total variance in  
the dependent variable which can be accounted for by the known 
variance in the independent variables.
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The initial analysis on each variable was a series of one-way analyses of 
variance examining each of the life-style factors independently. This 
analysis was carried out with the aim of exploring the data rather than 
to test hypotheses formally. The one-way analysis in a study such as 
this is very susceptible to detecting differences between the groups 
caused not by the factor under investigation but other factors which 
are not randomly distributed between the groups being tested. 
However, although this potential for confusion needs to be considered, 
the analysis can provide useful information which may help in the choice 
and interpretation of more sophisticated analyses. Stepwise multiple 
linear regression was then applied to each variable in tu rn .
Investigations of variability between individuals and the relationship 
with sex, age and lifestyle factors were carried out using step-wise 
multiple linear regression. Statistical analyses were carried out using 
the Genstat and Minitab statistical packages.
The chromosome aberration data were analysed by a series of statistical 
methods. Comparison between replicate cultures within an individual 
were carried out by Fisher’s exact tests. Comparisons between
groups exposed to differing ’life -s ty le ’ factors such as smoking or 
drinking were made using analysis of variance or pooled two-sample 
t-tests following arcsin transformation of the proportion of the 
individual’s cells that contained the class of aberration.
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Comparisons between the groups of exposed and control individuals 
were made using analysis of variance methodology and by 2X2 
contingency X 2 methods. In  the la tter case tests of the homogeneity of 
the proportions of aberrations within the control and exposed groups 
were carried out using the X 2 test of homogeneity of binomial values. 
Mutiple linear regression was also used to investigate all the Tlife -s ty leT 
factors simultaneously.
The data from each individual were summaried by expressing the 
number of aberrations as the total aberrations observed or as the 
number of cells showing aberrations. In  both cases the statistics were 
calculated including and excluding gaps.
The Ames test data were analysed by a 2 x 2 analysis of variance in  
order to investigate the effect of the different variables of the mean 
number of revertants per plate, per individual in the four groups of 
both strains.
(Note X 2 = Chi square.)
RESULTS
Mitogen- induced Blastogenesis
Dose response curves, decays per minute (dpm) against 6 log 
phytohaemagluttinin doses were drawn for each individual and examples 
are shown in Fig. 4 & 5. In  Figure 4 there is a suggestion of a 
bi-modal response. This is not the case in Figure 5. Dose response 
curves for the remaining individuals are included in Appendix 2.
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LEGEND -  FIGURE 4
Dose response curves of four different
individuals were obtained by measuring 
3
the average H thymidine incorporated 
(decays per minute -  dpm) into the 
lymphocytes as a result of stimulation to 
different concentrations of phytohae- 
magluttinin (PHA) (n g /m l).
The log of the PHA concentration was 
plotted (log ng/m l) against the response 
(dpm ).
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1
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LEGEND -FIGURE 5
Dose response curves of four different
individuals were obtained by measuring 
3
the average H thymidine incorporated  
(decays per minute -  dpm) into the 
lymph-ocytes as a result of stimulation to 
different concentrations of phytohaema- 
gluttinin (PHA) (n g /m l).
The log of the PHA concentration was 
plotted (log ng/m l) against the response 
(dpm ).
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0
Response to Mitogenic Stimulation 
of Four Individuals
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Those individuals who had relatively low maximal mitogenic response 
were included in the analysis. These were believed to be genuine low 
or non-responders, as distinct from technical artefacts, although the 
la tter was considered a possible explanation for the low responses. 
Data from 7 individuals where the values were zero were excluded. 
The maximal, sub-optimal and responses at 1 ng/ml of 
phytohaemagluttinin were determined for each sample and the values of 
the exposed and control groups were plotted as shown in Fig. 6 . As 
can be seen there was no statistical difference in the maximum response 
between the exposed (mean 28928±1524 S .E . )  and the control (mean 
28304±2483 S .E . )  groups although there was a suggestion of a bimodal 
response in the exposed group at lu g  1ml. The exposed and control 
groups were then categorised into various smoking, drinking and X -ra y  
categories. From Fig. 7, 8 , and 9 it  can be seen that there was no 
difference in these various categories, either in the control or exposed 
group, and this was confirmed by statistical analysis (Table 8 ) .  When 
the maximum phytohaemagluttinin response was plotted against the age 
of individuals there was a negative correlation both in the exposed and 
control group as can be seen from Fig. 10.
However, the effect, a reduction of 343 units per year of age, only 
accounts for 5% of the variab ility  as measured by step-wise multiple 
linear regression. There was a highly significant difference between 
the mean responses of different batches (p<0.001). The means ranged  
from a maximum of 49,302 in batch 4, to a minimum of 18,658 in batch
9. These results indicate that a considerable proportion of the 
variation between the 99 individuals was due to variation between the
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LEGEND -  FIGURE 6
From the individual dose response curves 
3
of H incorporation resulting from the 
different concentrations of phytohaema­
gluttinin (P H A ), the maximum response , 
the sub-optimal (maximum) response and 
the response to 1 jig/ml of PHA,decays per 
minute (dpm) were determined for each 
individual in the control and exposed 
populations and plotted.
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LEGEND -  FIGURE 7
The maximum mitogenic response (max 
response) in decays per minute (dpm) 
results from the incorporation of H 
thymidine obtained from the dose response 
curves of each individual was plotted 
against the corresponding smoking 
categories of each individual.
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LEGEND -  FIGURE 8
The maximum mitogenic response (max
response) in  decays per minute (dpm)
-3results from the incorporation of H 
thymidine obtained from the dose response 
curves of each individual was plotted  
against the corresponding drinking  
categories of each individual.
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LEGEND -  FIGURE 9
The maximum mitogenic response (max
response) in decays per minute (dpm)
3
results from the incorporation of II 
thymidine obtained from the dose response 
curves of each individual was plotted 
against the corresponding X —Ray 
categories of each individual.
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LEGEND -  TABLE 8
Maximal mitogenic response in control and exposed individuals
3
expressed as iimol H thymidine resulting from the incorporation
g
in 1.3 x 10 white blood cells per ml per individual as a result of 
phytohaemagluttinin stimulation.
N = Number of individuals
X = mean jimol thymidine
SE = standard error
Smoking Categories
Non = Non Smoker
Ex = Ex-Smoker
Cu = C urrent Smoker
D rinking Categories
Non = Non D rinker
Soc = Social D rinker
Reg = Regular D rinker
X-R ay Category
Non = Non-Exposed
Exp = Exposed over last during 12 months
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LEGEND -  FIGURE 10
The maximum mitogenic response (max
response) in decays per minute (dpm)
3
results from the incorporation of H 
thymidine obtained from the dose 
response curves of each individual was 
plotted against the age (years) of each 
individual in the exposed and control 
groups.
The corresponding regression line is
shown for all exposed ( -------  ) and all
control ( - ------------ ) individuals.
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batches, perhaps because of the variab ility  in the responses caused by 
differences resulting from technical factors. Further analysis by  
step-wise multiple linear regression confirmed the differences in  
response between batches indicating a reduction of 1403 dpm with each 
increasing batch number.
Proliferative Rate Index
Analysis were carried out on the satisfactory preparations of 
proliferative rate index from 80 individuals. No values were obtained 
. for 19 subjects. No significant differences were found in the analysis 
of variance between groups of individuals d iffering in their drinking, 
smoking habits (Figs 11 & 12), or their exposure to X -rays although 
from the figures, there is an apparent difference between the exposed 
and control groups within the same drinking or smoking category. 
There was, however, a significant difference in proliferative rate index  
between the 31 control and 49 exposed individuals (1.90 v  1.74: P<0.01) 
when all 13 batches of individuals were analysed (F ig . 13) and this 
explained the apparent difference within categories in Figs 11 and 12. 
Significant differences (P<0.001) were also seen in  the mean 
proliferative rate index values in the two sets of batches with mean 
proliferative rate index values ranging from 1.38 to 1.85 in batch 1 to 4 
and 1.51 to 2.19 in batches 5 to 13.
There wa£ no significant difference, however, between exposed and 
control individuals between the two sets of batches, j T h is  e l im in a te s  
any b io lo g ic a l  s ig n if ic a n c e  between exposed and c o n tr o l  w o rkers  
i n  term s o f  p r o l i f e r a t e  r a te  in d e x .
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LEGEND -  FIGURE 11 
PROLIFERATIVE RATE INDEX
The proliferative rate index (P R I) was measured for each sister 
chromatid exchange slide. This was accomplished by measuring the 
number of d ifferent metaphase divisions observed on slides prepared for 
sister chromatid exchange studies. The proliferative rate index was 
calculated by substituting the values for the number of cells in 1st, 
2nd and 3rd metaphase based upon the ir d ifferential staining with 
bromodeoxyuridine into the formula.
PRI = l (M I j  + 2 (M2) + 3(M3)
100
Where (M l = 1st Metaphase)
(M2 = 2nd Metaphase)
(M3 = 3rd Metaphase)
High values of proliferative rate index are indicative of a high rate of 
 ^p roliferation.
DRINKING CATEGORIES
0 = Non-Drinker
1 = Social D rinker
2 = Regular Drinker
Mean proliferative rate index (x ) and standard erro r ( --------- ) are
shown for both control and exposed individuals in  the different 
drinking categories.
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LEGEND -  FIGURE 12 
PROLIFERATIVE RATE INDEX
The proliferative rate index (P R I) was measured for each sister 
chromatid exchange slide. This was accomplished by measuring the 
number of different metaphase divisions observed on slides prepared for 
sister chromatid exchange studies. The proliferative rate index was 
calculated by substituting the values for the number of cells in 1st, 
2nd and 3rd metaphase based upon their differential staining with 
bromodeoxyuridine into the formula.
PRI = 1(M I) + 2 (M2) + 3(M3)
100
Where (M l = 1st Metaphase)
(M2 = 2nd Metaphase)
(M3 = 3rd Metaphase)
High values of proliferative rate index are indicative of a high rate of 
proliferation.
SMOKING CATEGORIES
0 = Non-Smoker
1 = Ex-Smoker
2 = Current Smoker
Mean proliferative rate index (x ) and standard erro r ( --------  ) are
shown for both control and exposed individuals in the different 
smoking categories.
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LEGEND -  FIGURE 13
PROLIFERATIVE RATE INDEX
The proliferative rate index (P R I) was measured for each sister 
chromatid exchange slide. This was accomplished by measuring the 
number of different metaphase divisions observed on slides prepared for 
sister chromatid exchange studies. The proliferative rate index was 
calculated by substituting the values for the number of cells in 1 st, 
2nd and 3rd metaphase based upon their differential staining with 
bromodeoxyuridine into the formula.
PRI = 1(M I) + 2 (M2) + 3(M3)
100
Where (M l = 1st Metaphase)
(M2 = 2nd Metaphase)
(M3 = 3rd Metaphase)
High values of proliferative rate index are indicative of a high rate of 
proliferation.
Values are shown for control and exposed individuals and the mean
proliferative rate index ( ° )  and standard errors ( --------  ) are
shown for each category.
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Step-wise multiple linear regression analysis suggested that there was a 
slight effect of age on proliferative rate index with a decrease in the 
proliferative rate index score of 0.0075 with each increasing year of 
age. (F ig . 14).
Sister Chromatid Exchange
Preparations (51) were suitable for analysis (23 control and 28 exposed 
individuals) for sister chromatid exchange. Of these, 36 individuals had 
duplicate cultures available. A hierarchical analysis of variance 
showed that there were both significant variation between these 36 
individuals and between the duplicate cultures (both P < 0 .001). 
However, the majority of the variation in the data was between cells 
(82%) compared with 14% between individuals and 4% between cultures. 
The between cultures variab ility  could be traced to 6 individuals where 
there were significant differences between the two replicate cultures as 
shown by a pooled two-sample t-te s t. There was no significant 
difference between the control and exposed individuals (F ig . 15). 
(Exposed: n=28, mean ± sd; 9.44 ± 2.00; Control n=23, mean ± sd; 8.95 
± 1 .62 ).
Despite the large variation between batches 1 to 4 and 5 to 13 (F ig . 16), 
the differences between control and exposed individuals within batches 
was small.
The variability  within groups provides an estimate of the power of the 
study to detect possible differences between two groups. Sample sizes 
of approx. 60 would be necessary for a 90% chance of detecting a 
significance of 1 sister chromatid exchange between two groups at the
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LEGEND -  FIGURE 14
PROLIFERATIVE RATE INDEX
The proliferative rate index (P R I) was measured for each sister 
chromatid exchange slide. This was accomplished by measuring the 
number of different metaphase divisions observed on slides prepared for 
sister chromatid exchange studies. The proliferative rate index was 
calculated by substituting the values for the number of cells in 1st, 
2nd and 3rd metaphase based upon their d ifferential staining with 
bromodeoxyuridine into the formula.
PRI = 1(M I) + 2 (M2) + 3(M3)
100
Where (M l = 1st Metaphase)
(M2 = 2nd Metaphase)
(M3 = 3rd Metaphase)
High values of proliferative rate index are indicative of a high rate of 
proliferation. Values are shown for exposed and control individuals in  
various age categories.
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LEGEND -  FIGURE 15
The average sister chromatid exchange per metaphase for each 
individual was obtained by analysing the firs t 25 consecutive 
well-spread second cycle metaphases from each set of slides. The 
cells counted were taken from 2 or more duplicate slides of each 
set, for both control and exposed individuals.
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LEGEND -  FIGURE 16
The average sister chromatid exchange per metaphase for each 
individual was obtained by analysing the firs t 25 consecutive 
well-spread second cycle metaphases from each set of slides. The 
cells counted were taken from 2 or more duplicate slides of each 
set, for each individual and the exposed and control groups 
categorised into batches. A total of 13 samplings were taken 
over a period of 13 weeks. A maximum of 8 individuals could be 
included in each sampling batch.
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5% significant level. Sample sizes of about 15 would be needed to 
detect a 2 sister chromatid exchange difference under the same 
assumptions. There was no difference in sister chromatid exchange 
values between the different smoking and age groups (F ig  17 and 18).
Chromosome Aberrations
The total number and types of aberrations per individual are shown in  
Appendix I I I  a, b and c. O f the 100 individuals recruited for the study  
one was excluded because he refused to complete a questionnaire. Of 
the remaining individuals 22. out of 99 produced cultures from which no 
metaphases could be scored. This left samples from 29 controls and 48 
exposed individuals where spreads could be evaluated. A total of 60 
individuals had two samples that could be scored and 17 where only one 
culture was scorable. Examples of chromosome aberrations from the 
study are shown in photographic plates 4, 5, 6 .
There was no evidence of significant differences between the duplicate 
cultures for any of the classes of aberrations from the 60 individuals 
using two-sided Fisher’s exact tests. Each of the classes of aberration  
was analysed in tu rn  using analysis of variance on the arcsin  
transformed proportion of aberrations per cell. One-way analyses of 
variance were carried out based upon the classification of the responses 
to the questionnaire. The considerable number of analyses performed, 
together with the potential confounding effects of various d ifferent 
factors, makes this statistical approach unsuitable for precise 
significance testing but useful for exploratory data analysis.
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LEGEND -  FIGURE 17
The average sister chromatid exchange per metaphase for each 
individual was obtained by analysing the firs t 25 consecutive 
well-spread second cycle metaphases from each set of slides. The cells 
counted were taken from 2 or more duplicate slides of each set, for 
both control and exposed individuals, and categorised into different 
smoking categories.
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LEGEND -FIGURE 18
The average sister chromatid exchange per metaphase for each 
individual was obtained by analysing the firs t 25 consecutive 
well-spread second cycle metaphases from each set of slides. The cells 
counted were taken from 2 or more duplicate slides of each set, for 
both control and exposed individuals, and the results are shown for all 
individuals in d ifferent age categories.
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PHOTOGRAPHIC LEGEND -  4, 5 and 6
Photograph showing cells at metaphase. Chromatid break is shown 
in chromosome No. 2, chromatid exchange Ttr i-ra d ia l’ and 
endoreduplication the la tte r showing a cell which has completed two 
synthesis ’ST phases without intervening cell division. The la tter 
is thought to be caused by an abnormality in the cell spindle or in  
cell division but can occur naturally at a low spontaneous rate .
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There were no significant analyses of variance apart from the analysis
using presence or absence of recent v ira l illness as a factor. The 5
subjects responding to this question had significantly raised numbers of 
gaps. (F [1 .75 ] =12.66 P<0.001; transformed mean and SD 8 . 86± 3.15 n=5 
versus 2.93± 3.63 n=72). However most of this effect is probably 
traceable to individual 14 where 3 gaps were found in the 50 cells from 
the single culture available for scoring.
Significant variation between batches was detected (F [11 .65] =2.84
P<0.01). This resulted from the 3 individuals from batches 5 and 6
where cells could be scored having no aberrations (or gaps) and from 
the higher frequencies in individuals in batches 3 and 12. Reanalysis 
excluding the 3 individuals from batches 5 and 6 reduced but did not 
remove the statistical significance.
The difference between individuals reporting a v ira l illness and the rest 
was again significant (F [1 .75 ]=  4 .56*) probably because of the number 
of gaps in the culture from individual 14.
Appendices I l ia ,  b and c show the total number of aberrations detected 
and Table 9 the average incidence over the control and exposed 
groups. The comparisons between the two groups were made in two 
ways. F irstly  by pooled two-sample t-tests  on the arcsin transformed 
proportion; secondly, by Fisher’s exact tests of the actual numbers of 
classes of aberrations. Both tests were one-sided, testing the 
hypothesis of increased incidence of aberrations in the exposed 
individuals.
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LEGEND -  TABLE 9
N = number of individuals who had preparations suitable for 
chromosome aberration scoring.
The Table shows the number of aberrations 
categorised by aberration type.
Totals for all abberrations and cells with 
aberrations are given including and 
excluding gaps.
TABLE 9
TOTAL NUMBER OF ABERRATIONS IN CONTROL & EXPOSED INDIVIDUALS
Control Exposed Total
N 29 48 77
Cells Scored 2481 4255 6736
Gaps 13 36 49
Chromosome Deletions 14 32 46
Chromosome Exchanges 1 5 6
Chromatid Deletions 11 33 44
Chromatid Exchanges 0 0 0
Hyperdiploidy 0 5 5
Others 2 0 2
Total Aberrations (incl.gaps) 40 111 151
Total Aberrations (excl.gaps) 27 72 99
Cells with Aberrations 
(incl.gaps) 37 103 140
Cells with Aberrations 
(excl.gaps) 25 69 94
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The parametric t-te s t approach showed no significant differences 
between the two groups, although in some cases such as the proportion 
of cells showing aberrations including gaps, the P value (Table 10) was 
close to significance in a one-sided test (P=0.06). In  all classes of 
aberrations except aberration classified as ’others’ the proportion of 
cells with aberrations were higher in the exposed than in the control 
group.
Analysis of the actual number of cells showing aberrations using
Fisher’s exact test showed highly significant increases in the exposed
group when all classes of aberrations were included especially when
gaps were included in the analysis (P=0.023 and P=0.006 respectively).
A number of the individual aberration classes were close to significance
at the P=0.05 level, particularly chromatid deletions (P=0.07). Such an
analysis assumes that the individuals within the group are homogeneous
2
in the ir responses. Tests for homogeneity (X  ) were carried out and 
significant heterogeneity detected within the exposed group (Table 11). 
(Note X 2 = Chi squared).
The transformed proportions of cells showing various classes of 
aberration were correlated with various other biological parameters 
measured in this study: maximum response, mean corpuscular volume, 
proliferative rate index, u rinary  phenol and sister chromatid exchange 
frequency. No significant correlations were detected except between 
different classes of aberrations and the aggregate measures of 
aberrations. The correlations, for instance, between the transformed  
proportion of cells with aberrations including gaps and the sister chro-
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LEGEND -  TABLE 10
N = number of individuals who had preparations suitable for scoring. 
SD = standard deviation.
The Table shows the number of aberrations categorised 
by aberration type.
Totals for all abberrations and cells with aberrations 
(ABS) are given including and excluding gaps.
The corresponding statistical values are shown for all 
categories for both the pooled t test and Fisher’s exact 
test.
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TABLE 11
CHI-SQUARE TEST OF HOMOGENEITY WITHIN CONTROL & TREATED GROUPS
Control Exposed
(n = 29) (n = 48)
X 2 (28) X 2 (47)
Gaps 31.06 NS 55.48 NS
Chromosome Deletions 41.17 NS 68.24 *
Chromosome Exchanges 23.82 NS 37.59 *
Chromatid Deletions 21.89 NS 72.00 *
Hyperdiploidy -------------  37.59 NS
Others 32.24 NS ------ ------
Total Abs (+ gaps) 41.64 NS 76.92 * *
Total Abs ( -  gaps) 41.02 NS 83.66 * * *
Cells with Abs (+ gaps) 40.41 NS 73.73 * *
Cells with Abs ( -  gaps) 35.44 NS 70.27 *
Key: NS = Not significant 
* = P<0.05
* *  = PC0.01 
* * *  = PC0.001
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matid exchange frequency of the same individuals was 0.150. (Note -  
only 46 individuals had measures for both sister chromatid exchange 
frequencies and chromosome aberrations).
Haematology and Biochemistry
No differences were detected in any of the biochemical parameters 
carried out. Individual values are shown in Appendix IV . This was 
also the case for the haematology values (Appendix V ) with one 
exception, where an analysis of variance gave a significant result: the
exposed individuals had significantly increased mean corpuscular 
volumes compared with the control subjects (9 3 .1 ,S .D .3 .2  v 91.5, 
S .D .4 .2  P<0.05). The distribution of the values are shown in F ig . 19 
where the values in control individuals ranged from 83 to 100 while the 
values of exposed individuals ranged from 87 to 99. No variab ility  was 
detected between the batches or for any other factor.
Although statistically significant, the differences between the control 
and exposed groups was small and the multiple linear regression 
showed that the difference in exposure between the two groups was 
responsible for only a small proportion (about 4%) of the total variation  
between the 98 individuals.
Urinary Phenol
The data from the 99 individuals are shown in Fig. 20. The 
distribution was skewed with a number of individuals having high 
values. One exposed individual had a value of 54 mg/1. There was
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LEGEND -  FIGURE 19
Histogram shows mean corpuscular volume (MCV) values for exposed and 
control individuals and the numbers of observations in each MCV category. 
The MCV gives an indication of the volume and thus the size of the red  
cells and is a ratio of the volume of red cells per unit volume and the 
number of red cells in millions per unit volume.
FIG 19
r
in
Histogram of mean corpuscular volume and number of
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LEGEND -  FIGURE 20
Histogram shows the number of observations in each u rin ary  phenol 
(mg/1) category in the control and exposed groups. The measurement of 
urinary  phenol in all individuals was as described by Baldwin et all 
(1981).
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no evidence of any significant effects in the analyses of variance for 
any of the factors on the concentration of phenol in the urine of the 99 
individuals in this study.
None of the life style factors ’helped’ to explain the between-individual 
variation when analysed by multiple linear regression.
Ames test data
Since in this study, urinary  phenol is used as an indicator of benzene 
exposure, individuals were selected and grouped into low and high 
phenol values. Those with the lowest and highest phenol values were 
investigated (range 1-7, 12-54 mg/ml respectively). Individuals were 
also matched for smoking and non-smoking, age, and where possible, 
alcohol intake (Table 12). The Ames Test data are presented in  
Tables 13, 14, 15 and 16, as mean revertants for the various
sub-groups.
There was no difference between the high urinary  phenol group and the 
low urinary  phenol group. However, in strain TA98, there was a 
significant increase in  revertants in smokers, by comparison with
non-smokers (P<0.05). The biggest source of variation in revertants  
was between individuals in  both strains, (P<0.001), whilst the 
variab ility  among triplicate plates was relatively small and insignificant.
In  strain TA98 there was no correlation between u rin ary  phenol values 
and revertants in smoking and non-smoking individuals (F ig . 21)
although there was a suggestion of a positive correlation between
revertants and the age of the individual (F ig .22).
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LEGEND -  TABLE 12
Individuals were categorised into 4 groups depending on 
whether they had relatively high (exposed) or low (control) 
urinary  phenol values, and whether they were smokers or 
non-smokers. Details of age, smoking category and the phenol 
concentration (level) in mg/1 are shown with mean values for 
age and urinary  phenol (m g/1) shown for the non-smoking 
and smoking categories and the total mean for both categories. 
For the purposes of this experiment, non (N ) and ex-smokers 
(EX) were treated with an equal weighting.
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LEGEND -  TABLE 13
Individuals were matched for age (pa ir number) with
corresponding values of S. typhimurium revertants in strains
TA98 and TA100 for each of triplicate sets of culture plates
with mean number of revertants per plate. A sparse lawn is
suggestive of plates unsuitable for counting.
Low phenol = control
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LEGEND -  TABLE 14
Individuals were matched for age (pair number) with 
corresponding values of S . typhimurium revertants in strains 
TA98 and TA100 for each of triplicate sets of culture plates 
with mean number of revertants per plate.
High phenol = exposed
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LEGEND -  TABLE 15
Individuals were matched for age (pa ir number) with
corresponding values of S. typhimurium revertants in strains
TA98 and TA100 for each of triplicate sets of culture plates
with mean number of revertants per plate. A sparse lawn is
suggestive of plates unsuitable for counting.
High phenol = exposed
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LEGEND -  TABLE 16
Individuals were matched for age (pair number) with
corresponding values of S. typhimurium revertants in strains
TA98 and TA100 for each of trip licate sets of culture plates
with mean number of revertants per plate. A sparse lawn is
suggestive of plates unsuitable for counting.
Low phenol = control
LO
W 
PH
EN
O
L/
NO
N 
SM
O
K
ER
z<
UJ
c o p o w w c o N W  
(O f s  If l  o i  CO CO N  N
o
o
CO
LU
H
<
CO
CVJ
^  TZ to  m
r^ * Z  in  ^
o  co in  o  r -  co
in  in  r  
CJ C l N
CM
CO
CO CO CM 
CO CO O
ZI
LU
O
QC
□L
CO
10 05 o  in  co ' cm co
CM T f  CM r -  N  ^  ID
CO
H
Z<
a:
UJ
sa:
CO
05
JS
CO
LU
H
<
<
LU2
CO
CM
w  n  o  o  w  o  s  o
CO* CO* CO* 05* O  ^  Ol o r - ^ m c o i n c o i ^
^  o  CO is  ^  
co co in  in  h-
T- co
M* CO CO
O 0 5 C 5 C M 0 5 C 0 £ * C 0
( o i n t o w w c o s
Z
i
LU
0cn
01 
CO
r O i n i f l W r r - O
i n o ^ i n N i n c o c o
CO
LU
-J
m<h-
oz
£<
CL
CM <0 ^  in  (O N  CO 05
119
LEGEND -  FIGURE 21
Ames Test revertants re fer to the mean number of salmonella typhimurium  
colonies in 3 cultures plotted against the phenol concentration in the 
urine of selected individuals categories into non-smoking and smoking 
groups.
FIG 21 MEAN NUMBER OF AMES TEST REVERTANTS IN URINE OF ALL SUBJECTS 
CORRELATED WITH PHENOL CONCENTRATION
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LEGEND -  FIGURE 22
Ames Test revertants re fer to the mean number of salmonella typhimurium  
colonies in 3 cultures plotted against the age (years) of selected 
individuals in non-smoking and smoking categories.
MEAN NUMBER OF AMES TEST REVERTANTS 
FIG 22 CORRELATED WITH AGE [YEARS] IN
ALL INDIVIDUALS
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DISCUSSION
Various parameters have been investigated in this human genetic study 
in the exposed and control workers. The study was controlled in that 
all reagents for genotoxic and kinetic analysis were purchased as one 
batch prior to beginning the study, with one exception which will be 
discussed later.
Mitogen-Induced Blastogenesis
The mitogen-induced blastogenesis data failed to show any effect 
between the control and the exposed group. Differences were, 
however, demonstrated between batches with respect to maximum 
response, in that high values were present in the firs t two batches 
with a similar effect being demonstrated with the proliferative rate
index data, where the values from the same batches were low.
The stepwise multiple linear regression showed a slight indication of an 
age effect leading to a reduction in maximum response, and proliferative  
rate index values with increasing age. The effect, i f  real, was very  
small. Nevertheless, the findings were consistent with those of
Campbell et al (1980) in their work with lymphocytes after asbestos
exposure and a similar effect has been described by Kishimoto et al 
(1978) who showed that the response to phytohaemagluttinin stimulation 
in human lymphocytes declined with age. Silverman et al 1975 noted that 
the phytohaemagluttinin response in his groups was increased in  
smokers under the age of 40, but failed to show an effect over the age 
of 40, implying that the effect over this period is either less marked or 
more variable.
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This present study was unable to demonstrate such an effect in the 
smoking groups. The suggestion of a bimodal response in the exposed 
group at lug /m l of PH A is interesting and might represent a d iffe r­
ential stimulation of lymphocyte sub-populations or types, rather than 
technical artefacts. This observation may warrant fu rther investigation.
Wolff and Bodycote (1985) have reported that whole blood cultures 
3
convert H thymidine into products which are not capable of incorpor-
3
ation into nuclei and suggest that incorporation of H thymidine may be 
an inaccurate measure of human lymphocyte proliferation. However in  
this study (and that of others eg Penhale et al 1974) there was no 
evidence of such an effect within an 18 hour labelling period.
Proliferative Rate Index
The proliferative rate index data indicated that there was a difference 
between the exposed and control individuals. In  addition there was a 
decrease of proliferative rate index with age. However, although the 
same batch of bromodeoxyuridine was used, a new solution was 
prepared for sister chromatid exchange and proliferative rate index 
determinations at week 5. It  is likely that the apparent variation in the 
proliferative rate index in control and exposed individuals is an artefact 
of the distribution of the individuals into different batches. This is 
supported by the observation that there are no differences in the mean 
proliferative rate index values of the two sets of batches of individuals 
resulting from the change of bromodeoxyuridine solution in week 5. 
Records indicate, however, that the two bromodeoxyuridine solutions 
were made up correctly and that some other unknown factor may be
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responsible for differences in batches of individuals such as seasonal 
variation as has been previously described by Littlefield and Goh (1973) 
and Sinha (1986).
Sister Chromatid Exchange
Despite batch variab ility , there was no difference in sister chromatid 
exchange between exposed and controls. A similar observation was 
made by Zhou et al (1986) for petrochemical workers. For the 
proliferative rate index data, there were unfortunately fewer controls to 
analyse by comparison with exposed values in batches 1 to 4, and this 
excess of low values of PRI in exposed workers could bias the data. 
For sister chromatid exchange in batches 1 to 4, of those samples that 
were suitable for analysis, control and exposed were more evenly 
distributed. I t  would appear that there are no real differences 
between exposed and control workers, either for proliferative rate index  
or sister chromatid exchange values.
Chromosome Aberrations The chromosome aberration data showed a 
slight, and depending upon the statistical test used, a significant 
increase in the incidence of aberrations (mainly chromatid deletions and 
gaps) in the benzene exposed group.
There is little  evidence of 'life style' factors influencing the incidence 
of aberrations in these studies apart from a few isolated observations. 
Individuals reporting recent v ira l illnesses had higher incidences of 
aberrations; a higher proportion of chromosome exchanges were in the
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oldest individuals in the study and there were significant reductions in  
two batches where cultures could be scored from only 3 of the 16 
individuals sampled.
Multiple linear regression of the proportion of cells showing aberrations 
including gaps also showed a significant reduction in gaps with an 
increased history of smoking. The biological significance ( i f  any) of 
this finding is unknown.
In  a study of this nature the possible confounding effects of many 
factors, any unintentional bias in the selection of the groups and the 
potential for mismatching of the exposed and control groups, can affect 
the results obtained. One or a small number of individuals with an 
increased incidence of aberrations can have a disportionate effect on the 
results observed. Depending upon the statistical methods used some of 
the differences were statistically significant, probably by chance.
Statistical analysis of such data is difficult especially when, as in this 
study, there is marked heterogeneity within a group (in ter-indiv idual 
variab ility) which can over estimate significance using a X 2 or Fisher’s 
exact test approach. Similarly, the large number of zero or small 
scores makes the use of an arcsin transformation in the analysis of 
variance (or its special case, the pooled two-sample t test) likely to 
estimate the significance of a comparison inaccurately. The hetero- 
ogeneity in the exposed group may be a consequence of sampling 
variability  or it  may represent a subgroup of either more exposed or 
more sensitive individuals.
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Further analysis of the individuals1 work history records who had the 
highest numbers of aberrations revealed no additional information to 
explain the differences.
Multiple regression by the best combination of other variables (in  this 
case, the Tlife styleT factors), found two factors which ’explained1 the 
incidence of aberrations. These were, whether the individual has a 
recent v ira l illness and whether he had been exposed to benzene. The 
best fittin g  regression line however, explained only a small proportion  
of the total variation in the 77 individuals (approximately 10%).
Haematology & Biochemistry The haematology and biochemical values 
showed no differences between exposed and control groups. The 
statistical analysis of the mean corpuscular volume data, however, 
showed a small difference between the exposed and control groups. 
Although differences in mean corpuscular volume have been described 
by Aksoy, et al (1971). Hutchings et al (1947) and Unger et al (1974) 
as an indication of marrow toxicity in alcohol and benzene poisoning, 
the absolute values observed in this study are within the normal clinical 
range (76-96fL).
Ames Test Data
The Ames Test Data on selected samples revealed no differences in the 
mutagenicity of the urine samples from high and low phenol groups. 
However, there was a significant difference in the number of revertants  
induced in strain TA 98 by samples from smokers in comparison with
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non-smokers. This has previously been described in strain TA 98 but 
not in TA 100 by Yamasaki and Ames (1977). There was also an 
increase in revertants with age in control and exposed individuals in  
strain TA 98, which is an interesting observation. No correlation was 
found between urinary phenol and the number of revertants in either 
strain. However, this is not surprising in view of the relatively low 
levels of phenol in urine present in this study, and that this biological 
monitor is known to be unreliable at exposures to benzene of less than 
25-50 parts per million, time weighted average.
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CHAPTER 3
CELL TRANSFORMATION STUDIES
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INTRODUCTION
The suitability of cell transformation systems as an experimental model 
for studying the possible mechansim of benzene carcinogenicity in terms 
of initiation, promotion, or both was considered to be valid given the 
experience gained by other workers investigating mineral oils in  
C3II10T£ cells (A . Wright personal communication).The experiments were 
designed to ascertain whether benzene would increase the frequency of 
transformants in the cell line on its own, or, after pre-treatment with a 
known carcinogen, or to exhibit promotional activity after a more 
prolonged treatment regime. However, only the in itiating phase of the 
experiment was completed for this current study.
MATERIALS AND METHODS
Reagents
Hank's solution was supplied by Northumbria Chemicals (address), 
Eagles minimal essential medium (EMEM) and foetal calf serum from Flow 
Laboratories, and Dulbecco's modified Eagles medium (DMEM) from Gibco 
Europe. The 15 mm Petri dishes were obtained from Nunclan, 
Denmark. The C3H10T1 cells (clone 8 , passage 13) were obtained from 
Professor Heidelberger, Comp. Cancer Centre, Los Angeles.
Toxicity Experiment
To determine the concentration of benzene that would be needed in the 
transformation assay, a toxicity experiment was performed.
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Preparation of Cells
Stock cultures of C3H10T£ cells in 5% Dulbecco’s Modified Eagles 
Medium were obtained and washed in approx. 20 ml of Hank’s 
balanced solution by gentle washing of the flask to dilute and 
remove excess serum. Any residual fluid at the base of the flask 
was removed by means of a pipette. Trypsin solution, 10 mis 
(0.25%) was then added to the flask, gently bathing the cells and 
after discarding this solution, 0.5 mis of trypsin solution were 
added and the flask was incubated at 37° for 2-3 mins. (max. 15 
m ins). The flask was then removed from the incubator and by 
gentle tapping of the flask, the cells were loosened and examined 
under the microscope. Eagle’s medium (10 mis of 10%) with added 
glutamine, streptomycin, penicillin and 10% of foetal calf serum 
were added to neutralise the action of the trypsin , and to dilute 
the cells was then aspirated to obtain a single cell suspension. The 
cells were then transferred from the flask into 25 ml universal 
tubes. The cells were counted in a haemocytometer and the cell 
suspension eventually diluted in order to give 2000 cells/ml. This 
cell suspension (0 .5  mis) was plated onto each of 50 culture  
vessels, each containing 4 ml of DMEM and were placed in an 
incubator at 37°C with 5% atmos-phere. A fter 24 hours the dishes 
were inspected and examined for cell growth.
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Preparation of Benzene Solution
A stock solution of benzene in dimethylsulphoxide was obtained 
from the formulation department (Shell, Sittingbourne) in  a 
concentration of 100 mg/ml. In  addition, a 10% dimethylsulphoxide 
solution in Dulbecco’s Modified Eagles Medium as a control was 
obtained. Dilutions of benzene in the same culture medium were 
made up to 10 ml to give final concentrations of 1000, 500, 250, 
125, 62.5, 31.25 15.63, 7.82, 3.91 ng/ml. A 0.5 ml sample of each 
solution was added to a separate 60 mm. petri dish, resulting in 10 
separate dose groups, 5 vessels in each group representing a 
solvent control and benzene concentrations of 3 .9 , 7 .8 , 15.6, 31.25 
62.5, 125, 250, 500, & 1000 |ig/ml. The dishes were then
incubated for 7 days 37°C in 5% COg.
Analysis
The petri dishes were removed from the incubator and the
solutions discarded. Each petri dish was washed with Hank’s
culture medium. The cells were fixed in methanol 100% for 10 mins. 
Giemsa Gurr's 10% was added for a fu rther 10 mins. for colony 
staining. Colonies were then counted manually.
Transformation Assay Experiments
Preparation of Cells
Stock cultures of C3H10T£ cells, approx. 90% confluent were
stained and processed in a similar manner to the toxicity
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experiment. Two cell solutions were made up in order to provide 
10000  cells/plate for the transformation assay and 1000 cells/plate 
for the cytotoxicity assay.
From the results of the toxicity experiment (Table 17 -  see 
Page 134 ) it  was decided to use three doses of benzene, viz 1000, 
500 and 250 jig per ml in dimethylsulphoxide, with 2 controls -  
dimethylsulphoxide and Methylcholanthracene (MCA) 2.5 ji/m l. 
Twelve 60 mm Petri dishes, each containing 4 mis of Dulbecco 
Modified Eagles Medium, were prepared for each of the 3 benzene 
doses and the 2 controls, giving a total of 60 dishes for the 
transformation assay. The respective cell solutions were added to 
the Petri dishes in 0.5 ml aliquots and placed in an incubator at 
37°C with 5% COg. A fter 24 hours the dishes were inspected and 
examined for cell growth.
Transformation Assay (Experiment 1)
Benzene stock solution (500 mg/ml) was made up into the three  
dose concentrations 1000, 500 and 250 ug/ml. The
dimethylsulphoxide and methyl cholanthracene ( 2 .5 |ig per ml) 
controls were also prepared. The solutions (0 .5  mis) were added 
to the corresponding petri dishes and placed in an incubator at 
37°C with 5% COg. The medium was changed twice weekly for the 
duration of the experiment (ie. a continous 5 week exposure) 
except for the positive control which was applied for 24 hours 
only.
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Cytotoxicity Assay (Experiment 2)
i
The cells were prepared in a similar manner to the transformation 
assay. On this occasion only 3 petri dishes were prepared for 
the 3 benzene and 2 control doses giving a total of 15 dishes.
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LEGEND -  TABLE 17
Results shown are for in itia l toxicity experiment when 
different concentrations of benzene were applied to each of 
5 dishes with colonies of C3H10T£ cells. Table shows the 
total number of colonies (Type I I  and Type I I I )  on each plate 
together with totals and mean for each benzene concentration 
category.
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A nalysis o f Transformation A ssay
After the 5 weeks, the petri dishes were processed and analysed in a 
similar way to the benzene toxicity experiment. However, on this
occasion, light microscopy was used to ascertain the type of foci. 
Although 3 types of foci can be identified in C3H10T£ assays, only 
Type I I  and I I I  were counted. Their characteristics were as follows:-
Type I I  Colonies showing massive piling up
of cells into dense m ulti-layers.
Type I I I  As Type I I ,  but cells assume a
pronounced spindle shape morphology 
giving rise to disorganised, 
bizarre, criss-cross cell arrangements.
Statistical analysis of cell transformation data has been the subject of 
much debate (Heidelberger et al 1983). The conclusions suggest that 
when a spontaneous transformation frequency approaching zero is 
established, the appearance of any transformed foci on treated plates is 
regarded as being a strong indication of a positive response.
RESULTS
The results of the experiment to investigate the cytotoxicity of benzene 
are presented in Table 17. The data shows that 1,000 jig/ml benzene 
gives an approximate LC 50 dose response. The results with the 
dimethylsulphoxide control indicate that the solvent may have made a 
small contribution to the cytotoxic response.
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As a result the transformation study was set up using 250, 500 and 
1000  |ig/ml of benzene as the test compound concentrations in the 
transformation assay. Furthermore, the benzene was used at higher 
stock concentrations in dimethylsulphoxide (eg 500 jig/m l) thereby  
allowing less DMSO to be applied to the test cultures.
The results of the transformation assay are shown in  Tables 18 and 19 
and are summarised in Table 20. The cytotoxicity data, (Table 18) 
shows cytotoxicity at 1 ,0 0 0  jug/ml in addition to the expected effects 
with methylcholanthracene as a positive control. The transformation 
assay data in Table 19 shows no evidence of transformation, especially 
at 250 and 500 fig/ml. However, although there were no transformed 
colonies there was an excessive amount of contamination at the l , 0 0 0 n 
mg/ml, thereby weakening any definitive conclusion. A repeat study  
without the contamination problems of the above, has since given no 
positive result at any dose level of benzene. The methylcholanthracene 
positive control which was applied to the cultures for 24 hours showed 
Type I I  and I I I  revertant colonies.
DISCUSSION
The CH310T£ cell transformation data showed no evidence of any 
transformed foci as a result of treatment with benzene at doses of 250 
and 500 jig/ml compared with the positive control. Unfortunately there  
was a high contamination frequency at the 1000  jig/m l, and no 
conclusion could be drawn from this dose level. This study has been 
repeated with completely negative results (A . Wright, Shell Research 
Laboratories, personal communication).
136
LEGEND -  TABLE 18
Plating efficiencies and transformation frequencies of C3H10t£ 
mouse embryo fibroblasts for the cytotoxicity experiment of 
the cell transformation assay. The benzene exposure was for 
8 continuous days and exposure to 3-m ethyl cholanthracene (MCA) 
for 24 hours only.
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LEGEND -  TABLE 19
Plating efficiencies and transformation frequencies of C3II10T£ 
mouse embryo fibroblasts for the fu ll transformation assay. 
The number of Type I I  and Type I I I  colonies are shown for each 
category. The benzene exposure was for 5 continuous weeks and 
exposure to 3-methyl cholananthracene (MCA) for 24 hours only.
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"Text continues on pl40"
Assay conditions for the promotion experiment would be identical to 
those described except that the cells would be pretreated with N-methyl 
-N-nitro-N-nitrosoguanidine , O .ljig /m l for 24 hours prior to plating.
This "initiated” target cell population would serve to monitor the 
promoting activity of benzene. Owing to time constraints and problems 
with contamination it  was thought prudent not to continue these 
experiments as part of this study. Nevertheless, such studies may 
provide important information as to the mechanism of action of benzene-fcjp^ 
carcinogens.
I t  is generally in ferred that the process of in vitro  cell transformation 
comprises both initiation and promotion stages. The fact that benzene 
did not display intrinsic transforming activity in this study implies that 
benzene does not possess overt in itiating properties. This conclusion 
is consistent with other short-term tests with benzene.
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CHAPTER 4
MOLECULAR DOSIMETRY
INTRODUCTION
32The P post-labelling method has been used to compare the binding of
alkenyl benzenes to mouse liver DNA in vivo by Randerath et al (1984).
As these compounds were similar to benzene, experiments have been
performed in Fisher 344 rats exposed by inhalation to undiluted benzene
(2,000 parts per million for 6 hours). In  these preliminary studies
32post-labelling with P of marrow and hydrolysed liver DNA of these 
rats showed no difference between exposed and control groups. (A  
Wright, Shell Research Laboratories, personal communication). 
However, similar patterns were seen in both control and the exposed 
groups, indicating that a background level of adduct formation probably 
occurs. No background was seen in the liver DNA of neonatal rats . 
Although there was no obvious qualitative or quantitative difference 
between the control and exposed groups in respect of the pattern of 
adducts in a particular tissue, different patterns were obtained for 
liver as compared with bone marrow. Similar findings have been 
observed by other workers and is currently the subject of much 
research. (A Wright, Shell Research Laboratories, personal 
communications).
14 . . .The C benzene experiments described m  this chapter were undertaken
in order to repeat the studies of A rfellin i et al (1985) and to provide a
32check that the failure to detect benzene adducts using the P 
post-labelling method was not due to technical reasons.
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MATERIALS AND METHODS
Materials
A Potter S Homogeniser (B raun ), liquid tight pots (Sorvol), metabowls 
(Jensons) a liquid scintillator spectrometer (Beckman), liquid scintil­
lator (Optiphase Safe) and corresponding vials (Packard) and the 
tr i-ca rb  sample oxidiser (Precision Instruments Packard) were provided 
by Shell Sittingbourne Research Laboratories.
Reagents
m-Cresol (99% pure) was obtained from Aldrich Chemical Company.
RNase A, RNase T1 and ethylenediamine tetracetic acid were obtained
from Sigma Chemical Company, Poole, Dorset. Bovine plasma albumin
(BPA) was obtained from Armour Pharmaceutical Company. 4
amino-salicylate, sodium salt (reagent grade), propan-2-ol (A ristar
grade) and all other chemicals (analar grade) were obtained from BDIi 
14Ltd. C-Benzene, 121 mCi per mmol (99.3% radiochemically pure) was 
supplied by Amersham International, Amersham.
Assessment of approximate dose of benzene needed for experiment
14Arfellini found that with 250 g rats dosed i .p .  with 32 fiCi of C - 
Benzene at 20 mCi per mmol-binding to the live r DNA observed was 6 
disintegrations per minute (dpm/mg) DNA (10 mg liver equivalent to 
250g of ra t ) .  Therefore, using benzene of specific activ ity , 120 mCi per
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mmol (x 6 ) for 30 mg DNA (3-4 livers) expect a total incorporation of 
14C should be around 1080 dpm, le. around 36 dpm per mg.
1Note 1 mCi = 3.7 x 10 becquerels
7
= 3.7 x 10 d .p .s .(d is in tegrations per
second)
= 3.7 x 107 x 60 d .p .m .
= 2 .2 2  x  10  ^ d .p .m .
g
So for each exposed to 1 mCi (2.22 x 10 dpm) benzene the expected 
incorporation into the total liver DNA should be circa 360 dpm.
Preparation of Dose
Five x 1 mCi ampoules were available. The vials (a & b) were 
stored at -20°C . When required, one vial was taken out and 
halfway submerged in Cardice. This was left in the Cardice for 30 
min. (Labels were removed from the vial in order to ease 
observation). The vial was opened by scoring followed by  
application of a hot piece of glass. A solution of re-d istilled  
dimethylsulphoxide (0 .4  ml) was added and mixed by careful 
rotation. The vial was then covered with Nescofilm and placed back 
in Cardice. The vials were then transferred to a rack in a fume 
cupboard and allowed to equilibrate at room temp. The volume was 
then made up to 1 ml by adding phosphate buffered saline.
144
Standardisation o f Dose
The contents of each vial was mixed thoroughly using a Hamilton 
type gas syringe and then a single sample of 2 pi was removed 
from each, and transferred to 100 ml volumetric flasks, which 
contained some 90 ml of DMSO. This was then mixed thoroughly. 
A sample of 100 pi was taken for counting.
-Quantitative Radioassay
Another vial (1 mCi) from the same bath was cooled in cardice. An
excess (around 3 ml) of unlabelled benzene was introduced above
the seal. The seal was broken using a metal rod and the 
14C-benzene solution was transferred quantitatively to a volumetric 
flask and made up to 100 ml using ethanol. Aliquots (1 ml) were 
diluted (x  1 0 0 ) with ethanol and duplicate 1 ml aliquots were 
counted
Monitoring of Opened Vials
Each vial top or bottom was rinsed with ethanol quantitatively into 
a volumetric flask and the washings diluted to 100 ml. Duplicate 
1 ml samples were counted.
Monitoring of Syringe
The syringe, now containing a minimal residue of the dose from 
vial ’b ’ was rinsed quantitatively, firs t with 50% ethanol/water, 
then with ethanol into a volumetric flask and the washings made up 
to 100 ml. Duplicate 1 ml samples were counted.
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Radioassay
All samples for radioassay were blended with 10 ml of liquid  
scintillator in polyethylene vials and counted in a liquid  
scintillation spectrometer with automatic quench correction. 
Appropriate backgrounds were determined and subtracted.
Animal Dosing
Rats (x4) from 6 starved male Fisher 344 (12 weeks old) were selected. 
Body weight was recorded. Each was injected intraperitoneally with 
half the contents of a single vial once in the morning and once in the 
afternoon (approx. 0.5 ml circa 0.5 milli Ci x 2 ). The animals were 
then placed in all glass metabowls for 24 h with free access to food and 
water. The animals were killed by terminal anaesthesia using lethobarb
i.p .  (1 ml per ra t) . The animals were dissected and a sample of blood 
obtained by cardiac punture prior to removal of the liver and both 
femurs. The livers were placed in liquid nitrogen. Marrow was obtained 
from the femurs by pareing the ends of the bones with a scalpel to 
expose the marrow cavity.
The bone marrow was then flushed into a tube, using phosphate 
buffered saline from a hypodermic syringe and needle, the la tter being 
used to agitate the cellular material free. The tubes were centrifuged  
for 10 mins. at 1600 g at 20°C. The pellets were then stored in  
stoppered tubes at -75°C . The livers from the liquid nitrogen were 
pooled and later weighed and stored at -75°C . The blood samples 
were placed in heparinised tubes, mixed on a roller mixer for 1/2 h .
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The cells were then sedimented and plasma removed and retained for
radioassay. The cells were washed three times by re-suspension in two
volumes of phosphate buffered saline and then re-centrifuged. The
washed pellets were stored at -75°C . A fter removal of the ra ts , any
suspended faecal pellets were dislodged into the collecting flask. The
flasks were removed, stoppered and stored at -20°C prior to
radioassay. The lower parts below the wire mesh rat platform of each
metabowl were washed down with a few ml of distilled water which was
allowed to drain into the urine collection flask. These flasks were then
14removed and the urine assayed for C. The urine, faeces and plasma 
were monitored as follows to determine the distribution and excretion of 
that dose:
Urine Eadioassay
Urine samples were transferred quantitatively to 50 ml measuring 
cylinders, made up to 50 ml with distilled water and mixed. 
Duplicate samples (1 ml) were removed for radioassay.
Plasma Radioassay
Samples (0 .1  ml) of plasma were blended with 1 ml Protosol in 
glass scintillation vials with polypropylene liners and heated at 55° 
for 1 h in a shaking water bath. To the clear aliquots, 10 ml of 
Optiphase Safe was added and the samples counted.
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A nalysis of Faecal Samples
The faecal pellets obtained from the rats were collected in round 
bottomed flasks attached to metabowls housing the rats. The 
faecal pellets were transferred to plastic containers and the weight 
of faecal pellets recorded. To these, distilled water was added to 
give a total weight of one and a half times the weight of the faecal 
pellets. This mixture was then homogenised on an Ultra Tu rrax  
homogeniser. The homogenates were assayed for radioactivity by  
combustion of the sample to carbon dioxide in an oxidiser which 
collected the gas in a liquid scintillator for counting.
Triplicate samples of the homogenate were analysed. Each sample 
was weighed into a combustion vessel. To this, one drop of 
combustion Aid liquid was added, followed by half a spatula of 
cellulose powder. The samples were then combusted over a cycle 
of 11/12 mins and collected for counting. Blanks were run in  
exactly the same way, but without sample.
The efficiency of the combustion was routinely determined by using 
14C impregnated paper strips (CFR101 ca 8000 decays per 
m inute/strip , Amersham International). Samples were combusted in
5
the presence and absence of an international standard (8.55 x 10 
+ /-  3% decays per minute/ml).
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Isolation and Purification of DNA from Rat Liver
Reagents
Phenol reagent I was made up as follows; phenol 1kg, m-cresol 
140ml, distilled water 110ml, 8-hydroxy quinoline l.O g. Phenol
reagent I I  was made up as follows; 8-hydroxyquinoline (0.1% w /v ) 
in phenol saturated with saline sodium citrate bu ffe r. (0.1M sodium 
chloride, 0.015M sodium citrate, p H 7 .0 ).
RNase solution consisted of 8 mg RNase A and 200 units RNase T1 
dissolved in 0.01M sodium acetate buffer pH 5.0 containing 0.1M 
sodium chloride and 0.5mg bovine plasma albumin ( weight/volume) .
The stored rat livers were thawed and then pressed through a 
stainless steel sieve and then homogenised with a Potter S 
homogeniser in 6% PAS in a ratio of 2 g of wet tissue to 15 mis of 
PAS. A sub-sample was then transferred for radioimmunoassay.
Phenol Extraction ( I )
Phenol reagent I was added in equal proportions (1 :1 ) to the liver  
homogenate in liquid tight containers. These were sealed and shaken in  
a reciprocating shaker for 1 hour at 120 cycles/min. They were then 
centrifuged at 13,000 rpm for 30 mins in  a Sorvol RC2 centrifuge.
From the resultant 3 phases, the top aqueous phase was pipetted off 
with a wide bore pipette, together with as much of the interphase as 
possible. This procedure was then repeated using a ratio of phenol to
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homogenate of 0 .5:1  by volume, and shaken for 15 min at 120 
cycles/min, removing the aqueous phase as before. The aqueous 
phase was then placed in a 1 litre  beaker and 2 volumes of ethanol 
meta-cresol (9 :1) were added, s tirring  with a glass rod, and in so 
doing the DNA wrapped around the glass rod. The resultant DNA was 
then placed in saline sodium citrate buffer (0 .1M ). This was then 
stirred for 24 hours. Potassium acetate (6M) was added in equal 
volumes and this was allowed to stand for 1 hour on ice. The latter 
was centrifuged at 10,000 RPM for 10 mins. The supernatant was 
pipetted as before, thereby leaving the precipated RNA (Ribosomal) and 
the DNA precipated, as before, using two volumes of cold ethanol in  
meta-cresol, collected on a glass rod and redisolved in saline sodium 
citrate. A fter 24 hours, the dissolved DNA was placed in centrifuge 
tubes and centrifuged at 35,000 RPM for 60 mins, thereby precipitating  
any glycogen. The supernatant was decanted off carefully and solid 
sodium chloride added in a ratio of 0.95 g/200 mis.
RNase Treatment
The residual RNA (messenger) was removed by adding RNase 
solution in a ratio to DNA solution of 1:100 at 80°C. The solution 
was then incubated for 1 hour at 37°C.
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Phenol Extraction II
Phenol reagent I I  was added to the DNA solution (1:1 v /v )  and 
extracted as before for 20 mins. This was then centrifuged as for the 
previous phenol extractions, and the resultant aqueous phase was 
pipetted o ff, but this time rigorously excluding the interphase or any 
phenol. Phenol extraction I I  was then repeated again, recovering the 
aqueous phase and an extraction performed 3 times with an equal 
volume of ether, thereby extracting any phenol which separated on the 
top. The lower DNA solution was transferred to a larger beaker (1 .5  
1) and solid sodium acetate was added in a ratio of 4 g per 100 ml of 
DNA solution. The DNA was precipitated by adding 2 volumes of cold 
redistilled 2 ethoxyethanol. The DNA was collected on a glass rod as
before. The DNA was redissolved in 18 mis of 0.1 saline sodium citrate,
and when dissolved 2 mis of 3M sodium acetate containing 1 mM ethylene 
diamine tetracetic acid. Finally, the DNA was precipitated by adding
10.8 mis of propan-2-ol. The precipitated DNA was collected onto a
\
glass rod as described before and drained. The DNA was washed with 
75% ethanol water, containing 1% sodium chloride, and then with 75% 
ethanol water only. This was repeated twice in each reagent for 2 
mins. The DNA was dried in a vacuum dessicator over phosphorus
pentoxide, and then radio-immunoassayed.
Statistical Analysis
Owing to the nature of the above experiment no statistics were 
performed on the data.
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RESULTS
14Table 21 shows the total dose of C received by each of the 4 rats,
derived from the summation of the two intraperitoneal doses. Table 22 
14shows the C content of the urine, plasma, faeces and live r. As can 
14be seen the C levels were relatively low. High excretory and plasma
levels were interpreted as indicating that high systemic concentrations
had been achieved. The pooled liver DNA from the rats treated with the 
14C-benzene/DMSO (ip ) contained 151 dpm per 39.2 mg of DNA, which
—6 - 6  is equivalent to 1.75 x 10 (iCi/mg of DNA and represents 2.54 x 10 %
(a) of the total dose.
DISCUSSION
14Preliminary experiments indicated a low level of C incorporation and a
need to pool the rat liver DNA prior to analysis. The pooled live r DNA
14from the 4 rats treated with C labelled benzene -  contained 1.75 x  
— fi10 fiCi/mg of DNA . The yield of DNA was approximately 50% of the
total. Therefore, the total amount of radio-nucleotide would have been 
—fi5.08 x 10 % of the total dose (2 x (a ) ) .  This level of radioactivity is
very  low and assuming that the DNA was 100% pure would correspond to 
an an alkylation frequency of 1 adduct (benzene equivalent) in 2.14 x
g
10 nucleotides (see Appendix 5 for details of calculation). This 
calculated alkylation frequency is likely to be an over-estimate. The 
DNA contained approximately 0.5% RNA and 1% protein. In  general 
binding of xenobiotics occurs in the ratio 100:50:1 for protein, RNA 
and DNA. Thus the alkylation frequency determined from these data is 
probably an over-estimate. Experimental errors are usually increased
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LEGEND -  TABLE 21
14Each of 4 rats received 2 doses of C (jiC i) benzene
dimethylsulphoxide (DMSO) intraperitoneally ( i . p . ) ,  giving  
total dose figure (iiC i) for each ra t. The total dose to
4 rats was 2.7mCi.
TABLE 21
DOSE VALUES OF 14C DERIVED FROM BENZENE EXPOSURE IN FOUR RATS
RAT VEHICLE ROUTE DOSE (fiC i) TOTAL DOSE
1 DM S O-ip 375 739
it 364
2 t r 342 679
IT 337
3 TT 488 803
Tt 315
4 IT 481 776
Key: DMSO = Dimethylsulphoxide
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LEGEND -  TABLE 22
14C content is expressed as a percentage (%) 
dose in different biological specimens.
14For live r C is expressed as jiC i/g  of ra t live r.
of exposure
TABLE 22
14C CONTENT IN THE URINE, PLASMA, FAECES & LIVER IN FOUR RATS
RAT URINE
(%
14C CONTENT 
PLASMA FAECES 
of total dose)
LIVER  
( jiC i/g  wet wt)
1 3.2 0.002 0.019 0.022
2 5.0 0.001 0.023 0.012
3 2.7 0.002 0.004 0.025
4 5.0 0.002 <0.001 0.019
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when an attempt is made to isolate purer DNA,eg. through spontaneous 
depurination reactions.
As a result of the very  low level of radioactivity, it  was decided that
this level precluded any fu rther analysis of the sample of DNA for the
14presence of adducts. Furthermore, there was not sufficient labelled C 
to detect the carbon label in a post-labelling experiment, as it  is known 
that the limit of detection for large molecules is in the region of 1 x  
10*^ and this limit would probably be decreased in a molecule the size 
of benzene (Watson 1987).
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CHAPTER 5
GENERAL DISCUSSION
The human genetic studies in chapter two did not reveal any great 
differences between the two groups examined. The dose response 
relationships obtained for the mitogen-induced blastogenesis were similar 
to those of Pfeifer and Irons (1982); in v itro  evidence on rodent 
lymphocyte activation in culture of rodents by Irons et al 1981 indicates 
that the effects can be demonstrated at concentrations of benzene 
metabolites (hydroquinone or p-benzoquinone) between 1 x 10^ to 10^M. 
However, it  has also been shown (Irons et al 1981) that complete 
protection against the suppressive action of benzene metabolites on 
lymphocyte activation is afforded by substances such as cysteine. 
Such protective mechanisms might be present in humans as distinct from 
rodents thereby preventing such effects being demonstrated in humans.
Furtherm ore, depending on the genotoxic end-point used to measure 
toxicity, benzene metabolites may present with varying orders of 
potency. Hydroquinone is a more potent inhibitor of lymphocyte 
activation than is catechol in v itro  (Wierda and Irons 1982). On the 
other hand catechol is more potent at producing sister chromatid 
exchange in human lymphocytes in culture (Morimoto and Wolff 1980). 
It  is possible that the metabolites produced in humans as a result of low 
level exposure to benzene are different and less potent in producing 
the effects under investigation than those metabolites produced at high 
exposure concentrates owing to the possible saturation of some 
metabolitic pathways. A lternatively the exposures received by the 
exposed group could have been below the threshold of such effects. 
As has been mentioned, although the exposures were relatively low,
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they could well have been much lower either as the result of increased 
process/fugitive emission control immediately prior to the study, or, as 
is more like ly , stringent adherence to respiratory protection proc­
edures which can reduce exposures a thousand fold.
The same reasoning could explain the overall results obtained in relation  
to the cell cycle kinetics (proliferative rate index) and sister chromatid 
exchange despite the fact that Styles and Richardson (1984) in their 
experiments with rodents had clearly demonstrated dose response 
relationships between benzene exposure and sister chromatid exchange 
induction at 1 parts per million.
Whereas sister chromatid exchange and possibly mitogen induced blasto- 
genesis effects are known to be relatively short term , chromosomal 
effects tend to be more persistent and therefore could reflect past 
exposures. Although the chromosome aberration data suggests a 
difference between the exposed and control groups, and despite the 
fact that many confounding variables were considered in this study, the 
interpretation of this and other studies in relation to benzene exposure 
can be d ifficu lt. More than 99% of the circulating lymphocytes are in the 
GO or G1 stage of the cell cycle and most chemicals such as benzene are 
S-dependent agents and in GO cells such as peripheral blood 
lymphocytes produce mainly chromatid-type aberrations. The majority of 
the abber-ations seen in this study were of the latter type. However
the biological significance of these aberrations is difficult to in terp re t.
9Nearly 50% of the approximately 500 x 10 lymphocytes of the human 
body are of the re-circulating type with a consequence that a large
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number of cells must be anatysed to get a representative sample of the
lymphocyte population: the analysis of 250 cells corresponds roughly to
g
a sampling of one cell per 10 . Depending on the number of cells 
analysed, the presence or the absence of chromosome aberrations can 
result from the size of the samples. When few cells are analysed this 
can create greater problems in interpretation. Human lymphocytes not 
only vary with respect to their individual response to substances such 
as benzene but also with respect to their mitogenic activation. At each 
cell generation about 50% of the unstable chromosome aberrations are 
eliminated (Conger, 1965; Sasakai and Norman, 1967; Carrano 1973; 
Carrano and Heddle 1973), and chromosome aberrations can develop 
from an original chromatid type aberration as a result of the second 
division of cells (Dolphin et al 1973).
As early as 48 hours after culture initiation, the culture time generally 
used in such experiments as those described, large numbers of second 
mitosis may already be present leading to an erronous estimation of the 
yield of aberrations produced. Furthermore studies on normal and 
irradiated human blood cells have shown (Evans 1984) that the incidence 
of gaps and chromatid aberrations in lymphocyte chromosomes increases 
as cells are allowed to proceed through two or more cycles in culture. 
The amount of chromatid aberrations detected in this study were similar 
to the yields of chromatid type aberrations in controlled populations as 
reported recently (reference Leonard et al 1986). In  addition, studies 
on irradiated persons have shown (Buckton et al 1967; Dolphin et al 
1973) that the majority (90%) of the human lympocytes have a life span
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exceeding three years, and some surviving more than 20 years. Since 
lymphocytes accumulate genetic damage they potentially allow for the 
monitoring of acute effects in addition all chronic effects from exposure 
to clastogenic agents. As a result the overall incidence of aberrations 
in the exposed group could suggest excessive exposure to benzene in  
the past. More detailed analysis such as banding could have
demonstrated more subtle effects resulting from recent low exposure but 
this was not performed in this study.
The Ames test experiments relied on a selection process based on 
urinary phenol estimations. Although this is known to be an
unreliable monitor for benzene at low exposures, it  is routinely carried  
out on those who are identified by job title  as being potentially exposed 
to benzene. The historical rationale behind this practice lies in its 
potential for measuring the amount of excess exposure during accidental 
spillages and was particularly useful during the cytogenetic study at 
the refinery referred to previously (Clare et al 1984). Although the 
measurement of exhaled benzene is now the biological monitor of choice, 
its widespread use in the United Kingdom has not occurred, and i t  was 
not possible at the design stage of this study to obtain the necessary 
agreement with the various parties involved to include this as the 
biological parameter of exposure.
The cell transformation data have indicated that benzene may not 
possess in ititiating carcinogenic properties using the 2 stage model of 
carcinogenesis. However, for completion, it  will be necessary to take 
into consideration the results of the second experiment investigating  
any promotional activity.
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The molecular dosimetry experiments suggested that the interaction of
benzene or its metabolites with DNA was of a low order of magnitude as
14indicated by the low level of binding of C to DNA. Possible
explanations for these results and the experiments with alkenyl 
32benzene using P are : -
1. Benzene or its metabolites may not form direct adducts with
DNA, but may create free radicals and perhaps reactive
oxygen species which react with DNA, and
2. As a result the methodology referred to for alkenyl
32benzenes using P may not be appropriate for benzene,
32Such "oxygen” adducts would escape detection by the P method and
32could explain the negative results associated with the P experiments
referred to in  the introduction to this chapter. Work is in progress to 
32extend the P methodology to all classes of DNA adducts, ie . to low 
molecular weight adducts and "oxygen” adducts, eg. 
8-hydroxyguanosine (A Wright, Shell Sittingbourne Research Labora­
tories, personal communication)
This study was unable to demonstrate any effects in the exposed 
individuals by comparison with control individuals between mitogen 
induced blastogenesis, proliferative rate index, sister chromatid 
exchange, urine mutagenicity or haematological/biochemical parameters.
The chromosome aberration data showed a statistically significant 
difference in the exposed group, either as a result of current 
exposures, or as a result of past cummulative benzene exposure.
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The cell transformation data did not suggest any initiating properties of 
benzene in the C3H10T£ cell line.
The molecular dosimetry data suggests that i f  benzene does react with 
DNA to form adducts, then this effect is weak. The objective of the 
experiments in Chapter 4, was to investigate the genotoxic action of 
benzene by its interaction with DNA. The evidence from this study 
suggests that i f  benzene is genotoxic it  is of a low order of magnitude. 
Alternatively, the genotoxic reaction may be indirect as shown 
schematically overleaf. (Table 23). Benzene metabolites may not form 
direct adducts with DNA, but by creating free radicals and perhaps 
reactive oxygen species may indirectly react with DNA, and as a result 
escape detection by experimental methods used in this study. It  is 
probable that multiple mechanisms are involved in benzene toxicity and 
carcinogenicity, and these may include synergism between different 
metabollites, such as benzoquinone and mucondialdehyde or synergism 
between glutathione-depleting metabollites of benzene and hydroxyl 
radicals, generated by futile cycling of cytochrome P-450 or possibly by 
redox cycling of quinonoid metabollites. Indeed, the formation of DNA 
adducts from metabollites of benzene may be of minor importance since 
the indications are that benzene and its metabollites are only weakly 
genotoxic, at least in humans.
It  is possible that benzene is an example of a mutagenic substance that 
does not react itse lf with DNA. The ability of benzene to produce
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T AISLE FObbliJLE GENOTOXIC ACTION OF BENZENE
Direct Genotoxic Reaction Indirect Genotoxic Reaction
BENZENE BENZENE
Nk
BENZENE METABOLITE
V
DNA
V
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(Mutagen)
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METABOLITE
V
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METABOLITE 
(eg.reactive 
oxygen species)
DNA
vl/
PRIMARY DNA DAMAGE 
(Mutagen)
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genotoxic end-points in animals and man (chromosomal aberrations/sister 
chromatid exchange/micronuclei) without evidence of mutagenicitity in 
short term tests causes one to consider other mechanisms such as 
alteration in gene expression without structural changes in DNA. 
Demonstrating any epigenetic effects is more difficult than genotoxic 
effects and was outside the scope of this current study.
Thus, i f  benzene’s genotoxic effect is weak, it  could explain the 
negative results in the cell transformation initiation studies and the 
overall results in the human genetic studies.
The exposure of the individuals in the human genetic studies was 
generally low. The effects of diet (glutathione, antioxidants) would be 
protective against the weak genotoxic insult resulting from the 
production of any reactive metabolites or oxygen species from such low 
exposures of benzene. (Tunek et al 1978).
There is little  doubt from the human epidemiology data that benzene in 
high doses causes a severe insult to the bone marrow in certain  
individuals and the relationship between high benzene exposure and the 
development of leukaemia is fa irly  convincing. The majority of the 
leukaemias in early studies occurred in those individuals with marrow 
toxicity. However, there were cases where the leukaemias occurred in  
the absence of marrow toxicity. In  all cases of occupationally induced 
cancer there must be a variation in terms of individual susceptibility. 
I t  is known that one of the reasons for this variab ility  may be the 
balance between activating and de-activating enzymes of the mixed
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function oxidases. It  has been shown that benzene is selectively 
metabolised (and selectively induces) one particular cytochrome P450 
enzyme i . e . ,  P448 and this effect has been associated with an increased 
myeloclastogenicity in male CD1 mice. (Gad-El-Karim et al 1985).
The balance between the activity of P448 and that of deactivating 
enzjrmes can be the determining factor in the expression of toxicity and 
this may be altered by factors such as hereditary, age, nutrition and 
diet (Parke and Ioannides 1981).
It  is known that, in general, at low levels of exposure, detoxication 
pathways usually predominate, activation to reactive intermediates is 
minimal, and as has been mentioned, these are usually effectively  
deactivated by protective intracellular substances such as glutathione. 
Higher exposures could saturate these detoxication pathways and give 
rise to the induction of other enzymes such as cytochrome P448, 
thereby enabling an increase in the amount of reactive intermediates 
e .g . ,  electrophiles. This could increase the genotoxic potential of such 
compounds.
In  the fu ture, it  would be interesting to conduct experiments using  
liver extract that has been produced from the livers of animals suitably 
treated with a chemical which would selectively induce the P448 fraction  
in the hepatocytes rather than Aroclor. This might result in the 
genotoxicity of benzene being easier to demonstrate in experimental 
models.
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Refinement of the molecular dosimetry techniques may, in time, identify  
the indirect production of mutagenic species that may result from 
exposure to compounds such as benzene.
This study has been unable to deduce whether benzene at low 
concentrations is a genotoxie agent in humans, except for some evidence 
of chromosomal damage which could either have been due to the 
exposures current at the time of this study, or to past cumulative 
exposures.
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APPENDICES
C O N F I D E N T I A L
Name . .  
Address
Dace of B irch  ....................................................
Marical Scacus ................................................
Number o f  Children ........................................
Time and Dace blood sample c a k e n ..........
T e l .  No. -  W o rk .................................................. Home
General P r a c c i c io n e r ' s  name  .............. ‘. ...............
address .................................
B r ie f  Job D escr ip c io n
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2 0 0
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LEGEND -  APPENDIX I lia
IDNO = Identification number oi
G = Gap
CSMDEI = Chromosome Deletions
CSMEXC = Chromosome Exchange
CTDDEL = Chromatid Deletions
CTDEXC = Chromatid Exchange
HYPDIP = Hyperdiploid
TAB = Total Aberrations
CAB = Cells with Aberrations
With Gap
Without Gap
individual
1 C 6 C
D E A S
L p M
N L s 0
0 S E
L
1 100 1
2 100 1 1
3 100 1 1
4 100 1
5 100 3 1
6 100 1
7 50
8 100 1 2
9 25 . -
10 100 -
11 100 1
12 50 1
13 50
114 50 3
15 100 1
16 100 2 1
17 50 1
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21 100 - 1
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25 100 1
26 100 1 2
32 SO
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47 100 2 1
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58 80
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60 100 1
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ove p tWO c u l t u r e s where a p p r o p r i a t e . )
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1 • 2 2 2
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1 1 1
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1 1 2 2 1 1
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2
*
3 3 3 3
2 3 2 3 2
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4 1 7 5 6 4
2 4 4 3
2 - 8 7 7
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1 4 2 4 2
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LEGEND -  APPENDIX Illb
IDNO
G
CSMDEI =
CSMEXC =
CTDDEL =
CTDEXC =
HYPDIP =
TAB
CAB
Identification number o f individual
Gap
Chromosome Deletions
Chromosome Exchange
Chromatid Deletions
Chromatid Exchange
Hyperdiploid
Total Aberrations
Cells with Aberrations
With Gap
Without Gap
Summary o f  a b e r r a t i o n s  found in  th e  29 c o n t r o l  i n d i v i d u a l s .  
( C o u n t s  summed o v e r  two c u l t u r e s  where a p p r o p r i a t e . )
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LEGEND -  APPENDIX IIIc
IDNO = Identification number oi
G = Gap
CSMDEI = Chromosome Deletions
CSMEXC = Chromosome Exchange
CTDDEL = Chromatid Deletions
CTDEXC = Chromatid Exchange
HYPDIP = Hyper diploid
TAB = Total Aberrations
CAB = Cells with Aberrations
With Gap
Without Gap
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a p p e n d ix  VI
CALCULATION OF ALKYLATION FREQUENCY FROM BINDING OR 
RADIOACTIVITY TO DNA
Binding of C ^  to liver DNA from rats exposed to (C^S benzene 
(Specific Activity 121 Ci/mol) was 151 dpm/39.2 mg DNA.
1. Calculation of number of molecules bound to DNA
From Spec Ac = 1 2 1  Ci/mol
= 121 x 3.7 x 1 0 ^ x  60dpm per mo
23No. of molecules per mol * 6.023 x 10 (Avogadro's No.)
= 121 x 3.7 x 1010 x 60 dPm Per
23
6.023 x 10 molecules.
Hence 151 dpm corresponds ..to 6023 x 10^ x 151 - A
121 x 3.7 x 1010 x 60
2. Calculation of nucber of nucleotides in DNA 
For manmalian DNA use conversion factor
1 mg DNA 1.85 x 10^ nucleotides
Therefore, 39.2 mg DNA * 39.2 x 1.85 x 10^ nucleotides B
Assuming only one molecule of chemical reacts per DNA base 
(ie to give mono-adduct).
Alkylation frequency expressed as No. of nucleotides per adduct =
B
A
Therefore Alkylation frequency (AF)
_39.2 x 1.85 xlO18 x 121 x 3.7 x!010x 60 
6.023 x 1023 x 151
Q
Alkylation frequency = 1 adduct in 2.14 x 10 nucleotides
